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Abstract 
Breastfeeding is unquestionably the best nourishment for infants. Current 
epidemiological as well as experimental evidence has repeatedly demonstrated the 
nutritional, immunological, and psychosocial benefits attributable to breastfeeding. However, 
suboptimal breast health may compromise maternal ability to breastfeed and the well-being 
of breastfeeding infants. Subclinical mastitis (SCM) is an asymptomatic inflammatory 
condition of the lactating breast that is associated with a number of adverse outcomes 
including lactation failure, infant growth faltering during the early postpartum period, and 
increased risk of mother-to-child transmission of the human immunodeficiency virus (HIV).  
Three studies were carried out in Ghana with the overall aim of describing the 
mechanistic pathway(s) linking SCM and infant growth faltering. The specific objectives of 
the studies were to determine: 1) the prevalence of SCM among lactating women in Ghana, 
2) whether SCM is associated with reduced breast milk intake by the infant, and 3) whether 
SCM occurring beyond the third month postpartum had an adverse effect on infant growth 
between the third and sixth month postpartum. Two cross-sectional studies were designed 
with respect to the first two objectives. Data were collected in a longitudinal study to 
examine the third objective. 
All data from the three studies were collected from infant-mother pairs residing in the 
Eastern region of Ghana. Maternal data included demographic, health, and anthropometric 
data as well as breast milk samples that were analyzed to determine maternal SCM status. 
Maternal SCM was primarily diagnosed as elevated breast milk sodium:potassium ratio 
(Na/K) above 1.0. California mastitis test (CMT) was also used in the cross-sectional studies 
to diagnose SCM. Infant breast milk intake was estimated using the test weighing procedure. 
Infant data included feeding, health, and growth measured as weight, length, head 
circumference, and mid-upper arm circumference.  
xii 
 
 
In the first cross-sectional study, SCM (Na/K>1.0) was observed among 45.3% of 
women at three or four months postpartum. About 30% of the observed SCM occurred in 
only one breast. In the second cross-sectional study, infants whose mothers had Na/K > 1.0 
as well as CMT score ≥ 1 had significantly lower breast milk intake (-88.9 g; 95% CI: -171.1 
g, -6.9 g). However, the observed milk intake difference across SCM groups disappeared 
when infant weight and feeding frequency were controlled in multivariate analyses. The 
longitudinal study did not find an association between maternal episodes of SCM (Na/K) 
occurring between the 3rd and 6th month postpartum and infant growth occurring during the 
same period. 
In conclusion, our results indicate that SCM is a common condition among women in 
the Eastern region of Ghana. However, we did not find a reduction in breast milk intake of 
infants whose mothers had SCM. There was, also, no association between maternal SCM 
occurring between the 3rd and 6th postpartum and infant growth during the same period. 
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Chapter 1. General Introduction 
The dissertation is organized into seven chapters as follows: general introduction, a 
review of the relevant literature, general methods, and a chapter each for manuscripts of three 
reports prepared in a format suitable for submission to peer-reviewed journals. The final 
chapter is general conclusions. An appendices section detailing the data collection tools and 
informed consent documents is included at the end. All references cited in the dissertation, 
excluding those in the three journal manuscripts, are listed in Arabic numeric order in a 
references section to be found after the general conclusions. References cited in the journal 
manuscripts are included at the end of each respective chapter.  
Background 
Breastfeeding is unquestionably the best nourishment for infants. Current 
epidemiological as well as experimental evidence has repeatedly demonstrated the 
nutritional, immunological, and psychosocial benefits attributable to breastfeeding.1-3 These 
benefits are derived from the unique formulation of anti-microbial, immunoactive, and 
growth factors as well as the highly bioavailable macro- and micronutrients in human milk.4-7 
It is no surprise, therefore, that study after study in many different settings continue to report, 
unambiguously, the strong relationship between breastfeeding and reduced risk of infant 
malnutrition, morbidity, and mortality.  
In recognition of the numerous benefits attributed to breastfeeding, global efforts 
have been instituted to promote and sustain breastfeeding practice. Beginning from the early 
1980’s, the international code on the marketing of breast milk substitutes was adopted by the 
34th session of the World Health Assembly in 1981.8 The code was designed as a set of 
regulations to preserve and promote appropriate breastfeeding practice and also to stem the 
tide of rapid breastfeeding decline that was being fueled by unethical marketing of 
commercial breast milk substitutes. The Innocenti declaration in 1990 and subsequently the 
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Baby Friendly Hospital Initiative (BFHI) instituted by the United Nations Children’s Fund 
(UNICEF) in 1991 are two other notable efforts to promote breastfeeding practice.9  
The World Health Organization currently recommends that all infants, with the 
exception of those born to HIV-infected mothers, be breastfed exclusively during the first six 
months of life with subsequent introduction of complementary feeding starting around the 
sixth month.10 Current estimates indicate that breastfeeding is initiated by more than 90% of 
women globally.11 However, only 39% of infants less than six months are exclusively 
breastfed.12 
The primary reason given by most women for suspending breastfeeding is maternal 
concern about inadequate milk supply.13,14 Maternal factors such as late onset of lactation, 
breast/nipple soreness and infant factors including gender, latch problems, and poor weight 
gain have also been cited as reasons for breastfeeding cessation or early introduction of 
complementary feeds.15-17 Where available, lactation support to women during pregnancy or 
after delivery has been effective at reducing breastfeeding problems and subsequently 
improving breastfeeding practice.18-21  
Successful breastfeeding may also be affected by maternal conditions that are not 
obvious to the mother. Subclinical mastitis (SCM) falls into this category. SCM is an 
inflammation of the lactating breast and has only recently been clearly characterized in the 
human lactation literature.22 In dairy cattle, however, SCM has been described and 
extensively studied because of its adverse effects on milk production.23 Interest in maternal 
SCM has grown because of the reported association of SCM with elevated risk of HIV 
transmission.24,25  
SCM may occur for several reasons including localized inflammation of mammary 
tissue resulting from milk stasis, localized breast infection, physical breast tissue trauma,26 
mammary gland involution due to reduced breast milk production,27 micronutrient 
deficiencies,28,29 and systemic infection.30 Poor lactation practice and weak suckling by the 
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infant have been associated with SCM.27,31 The mammary tissue inflammation occurring 
during SCM leads to involuntary opening of the tight junctions cementing alveolar cells. 
Consequently, there is a net leakage of inflammatory cells and other plasma components 
including sodium and chloride ions into breast milk and a simultaneous efflux of potassium 
ions out from milk into plasma to maintain ionic balance.32-34 An elevation in breast milk 
sodium potassium ratio (Na/K) has been found to correlate significantly with the 
inflammatory cytokine, interleukin 8, and therefore Na/K is considered a marker of 
mammary inflammation.28  
In a study of lactating women in the United States, Morton35 found an association 
between elevated breast milk sodium content and lactation failure. Children of the affected 
women gained less weight at one month postpartum than those whose mothers did not have 
elevated sodium. Similar infant growth faltering associated with elevated breast milk Na/K 
has subsequently been reported among infants in Bangladesh and Zimbabwe at 3 months and 
4.5 months, respectively.36,37  
The epidemiology of SCM is not as well characterized as clinical mastitis which is 
well described in the human lactation literature. Bilaterally elevated breast milk sodium is 
typical of early lactation and reduces by the 14th day postpartum.5,34,37 This reduction is 
attributed to the closure of paracellular pathways in the mammary epithelium just before 
onset of lactation.34 However, the unilateral elevation in breast milk sodium, typical of SCM, 
is persistent and occurs in response to mammary inflammation.38 Moderately elevated Na/K 
between 0.6 and 1.0 has been reported in 16% of Bangladeshi women at 4 weeks 
postpartum.21 In Zimbabwe, a moderate increase in Na/K was reported among 10% to 15% 
of HIV uninfected women and 12% to 21% of women infected with HIV during the first 4 
months postpartum.37 The rate of severely elevated Na/K (> 1.0) has a wide range: 9% at 1 
month36  and 22.4% at 6 weeks in South Africa.24  
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Typically, the rate of elevated Na/K declines over time. At 3 months postpartum, 
reported rates of elevated Na/K include 11% in Tanzania28 and 12% in Bangladesh.21 
Willumsen et al.24 have reported unusually high rates of severe unilaterally elevated Na/K of 
22.9% among lactating HIV-infected women at 14 weeks postpartum. In this group of 
women, prevalence of severely elevated Na/K in one or both breasts was 25.3%, excluding 
those with moderate Na/K who usually constitute a larger proportion. Another study 
assessing SCM as elevated breast milk sodium (> 12 mmol/L) found about 16% of lactating 
women in Malawi had SCM at six weeks postpartum.4 Another study has suggested that 
markers of SCM may be observed even at 12 months postpartum.39 Studies by Dewey et al.31 
have reported that the weaning period is associated with elevated milk sodium levels, 
indicative of SCM. These studies suggest that SCM is a common occurrence among lactating 
women. There is a need, therefore, for further studies to fully understand factors that result in 
SCM as well as the pathways that lead to the stated infant and maternal outcomes of 
mammary inflammation.  
Currently, the mechanism relating SCM with infant growth faltering remains 
undefined. In lactating cattle, SCM is associated with decreased milk production. It has also 
been reported that calves nursed by beef cows with SCM experience significant decrease in 
weight gain.40 Kirkbride41 had earlier reported that the weight that calves fail to gain due to 
mammary infection can be recovered with mastitis treatment. These studies suggest that 
SCM may be associated with a decline in the ability of mammary epithelium to produce 
enough milk to meet the needs of the growing calf. A similar mechanism may be occurring in 
human infants although there is no evidence from human studies. Prentice et al.26 have 
reported that clinical mastitis may be associated with destruction of secretory mammary 
tissue with consequences for subsequent lactational performance. 
 Another mechanism that may explain infant growth faltering as a result of maternal 
SCM is decreased milk acceptability by the infant that translates into decreased milk intake. 
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Conner42 has reported the case of an infant who preferred sweet milk produced from a 
normal breast as opposed to ‘salty’ milk produced by the mother’s other breast that had 
elevated sodium. In such a situation, infant milk intake may be affected directly or indirectly 
through reduced emptying of the affected breast, which is known to affect milk output.43 In 
such a situation, the bulk of the infant’s intake will then be coming from the unaffected 
breast. Whether the unaffected breast alone is capable of producing enough milk to meet the 
nursing demands of the infant depends on the ability of the mother to practice breastfeeding 
behaviors that increase her milk supply. However, studies have shown that when mothers 
have concerns about low milk supply, they are likely to introduce other foods or wean their 
children.16,17 We hypothesize therefore that SCM affects infant growth by reducing infant 
milk intake through two possible pathways: 1) reduced acceptability of milk and 2) reduced 
milk output resulting from either involution of mammary tissue, inadequate breast emptying 
or both.  
To understand the relationship between SCM and infant growth faltering, we carried 
out three studies on infant growth and subclinical mastitis in Ghana between 2005 and 2006. 
The first study was a rapid survey to determine the burden of SCM among Ghanaian 
lactating women. Subsequently, we tested our hypothesis that SCM will reduce infant milk 
intake by recruiting a different sample of lactating women and their infants to observe infant 
milk intake. Our third study examined the association between SCM and infant growth 
faltering among breastfeeding infants beyond early lactation in a cohort of infant-mother 
pairs.  
Previous studies investigating the association between SCM and infant growth have 
focused on the first three months postpartum period. Our current studies investigated the 
effects of SCM beyond the early lactation period. This period was also of interest because it 
coincided with the introduction of other foods (i.e., mixed feeding) to the child. Willumsen et 
al. (2000) have shown that mixed feeding is associated with elevated risk of SCM.44   
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Specific aims and hypotheses 
The specific aims and hypotheses of the studies included in this dissertation are: 
1. To determine whether SCM is prevalent among lactating Ghanaian women.  
Hypothesis: Prevalence of SCM beyond 3 months postpartum is in excess of 20%   
among lactating women in Ghana. 
 
2. To determine the relationship between maternal SCM and infant breast milk intake.  
Hypothesis: SCM is associated with a decrease in infant breast milk intake.  
 
3. To determine the relationship between maternal SCM and infant growth beyond   
the third month postpartum. 
Hypothesis: SCM is associated with a decrease in weight and length gain in  
breastfeeding infants.  
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Chapter 2. Literature Review 
Breastfeeding is recommended as the ideal way of feeding infants.10 Breast milk 
provides essential nutrients, immunoactive proteins, antimicrobial factors, and other 
bioactive constituents that have been associated with reduced risk of morbidity and mortality 
among breastfed infants.45 Many studies have shown that infants benefit from breastfeeding 
in a dose-dependent manner;46 exclusive breastfeeding during early lactation as well as 
longer breastfeeding duration are both associated with less risk of infant morbidity and 
mortality. These findings form the basis for the recommendation of breastfeeding as a critical 
public health intervention to reduce infant morbidity and mortality, especially in low income 
settings where the risk of infections is often high.1  
Breastfeeding and young child survival 
Many studies have shown that breastfeeding is associated with increased infant 
survival, especially for infants below 6 months.45,47 Children who are breastfed derive 
nutritional, psychosocial, as well as immunological benefits from breast milk. Observational 
studies in low income settings have demonstrated that breastfeeding, either exclusively or 
partially, is associated with decreased risk of many childhood diseases among both full term 
and preterm infants.48,49 Protective effects of breastfeeding have been observed specifically 
for diarrhea,50 respiratory infections,51 and necrotizing enterocolitis.52  
These benefits have been demonstrated in experimental studies as well. In a quasi-
experiment in which Iranian women were given breastfeeding education, Froozani et al.53 
reported a lower mean number of days of diarrhea (p < 0.004) among infants in the 
experimental group who had a higher exclusive breastfeeding (EBF) rate (54%) than those in 
the control group in which EBF was low (6.5%). In the same study, children in the 
experimental group also had mean weights and lengths that were significantly higher (p < 
0.05) than those in the control group. A recent breastfeeding trial in Belarus assigned mothers 
with intention to breastfeed to either a control group or an enhanced baby friendly hospital 
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initiative intervention.54 After 12 months of follow-up, the study demonstrated a 40% 
reduction in risk of gastrointestinal infection among infants in the intervention group who 
had increased rates of EBF at both 3 and 6 months postpartum.  
Breastfeeding is also known to reduce the mortality risk due to diarrhea and 
respiratory diseases by almost four-fold.2 Some studies indicate that the risk of all-cause 
mortality is greatest in the first few months if a child is not breastfed.46,55,56 Because the 
protection offered by breastfeeding increases with the dose of breastfeeding, the greatest 
mortality risk occurs among non-breastfed46,57 and bottle-fed infants.58 Non-breastfed 
children below 5 months have a 5-fold higher risk of dying compared to breastfed children of 
similar age.46 
In a study of Latin America and Caribbean infants, EBF during the first 3 months and 
partial breastfeeding during the remainder of the first year of life prevented 55% of infant 
deaths related to diarrhea and acute respiratory disease and 66% of deaths among infants 
below 3 months due to both diarrhea and respiratory infections.59 In the same group of 
children, about 14% of all-cause infant mortality was prevented by EBF. A meta-analysis of 
prospective and case-control studies of breastfeeding demonstrated that breastfeeding 
decreases the risk of mortality due to diarrhea (odds ratio 6.1; 95% CI, 4.1-9.0) and acute 
respiratory infections (2.4; 95% CI, 1.6-3.5) of children in the first 6 months of life.60 
Benefits of breastfeeding beyond infancy  
The benefits of breastfeeding persist beyond infancy. In a meta-analysis of 20 studies, 
Anderson et al.61 reported that children below 16 years old, who had been breastfed as 
infants, demonstrated superior motor and cognitive abilities compared to formula-fed, even 
after adjusting for child age and maternal socio-demographic factors. Among this age group, 
the evidence supported a dose-dependent effect of breastfeeding on cognitive function. In a 
prospective cohort of Australian children, the risk of asthma at 6 years of age was less if the 
duration of exclusive breastfeeding was at least 4 months.62  
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Several studies have also demonstrated an association between having been breastfed 
as an infant and a reduced risk of developing various chronic disorders including 
premenopausal breast cancer,63,64 leukemia and lymphoma,65 and other cancers.66 Beneficial 
breastfeeding outcomes have also been reported for the risk of cardiovascular diseases,67,68 
diabetes mellitus,69 and obesity in adulthood.70 
Effects of breastfeeding on maternal health 
Among women, breastfeeding is associated with maintenance of a healthy body 
weight postpartum and a reduced risk of obesity.71 Kramer et al.72 have reported significant 
postpartum reductions in hip circumference among women breastfeeding either exclusively 
or partially, although the mechanisms involved have not been established. Brewer et al.73 
have reported significant reductions in postpartum weight of lactating women between the 
third and sixth month only among EBF women compared to formula-feeding or mix-feeding. 
A recent study by Kac et al.74 concluded that prolonged breastfeeding contributes to a 
decrease in postpartum weight retention among Brazilian women. This is in agreement with 
an earlier study among Australian women in which excess postpartum weight gain was 
associated with early cessation of breastfeeding.75 Among another cohort of Brazilian women 
who were observed over a period of five years postpartum, both body mass index and 
percentage fat mass, determined by bio-impedance, were lowest for women who breastfed 
for 6-11 months and highest for those who breastfed for less than one month.76  
However, a prospective study of lactating mothers failed to establish a consistent 
relationship between lactation and weight loss between 6 weeks and 12 months postpartum.77 
Parker and Abrams78 have suggested that postpartum weight retention may be racially 
determined. Their study found that black mothers were twice as likely to retain at least 20 
pounds more weight postpartum than white mothers. However, since breastfeeding duration 
was not controlled in this study, the results may only be reflective of low breastfeeding 
practice among black women.79 Differences in cultural perceptions of body composition and 
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weight loss my also explain the differences across races. However, the effects of cultural 
differences on postpartum weight loss have not been reported. 
On-demand breastfeeding is associated with reduced incidence of ovulation80 and 
thus reduced fertility. The biological basis underlying this phenomenon is explained by the 
disruption of the normal pattern of gonadotropin releasing hormone secretion during 
breastfeeding, which results in reduced luteinizing hormone secretion from the pituitary 
gland.81 Ultimately, a failure of follicle development is induced. This physiological process 
forms the basis of the birth control technique known as the lactational amenorrhea method 
(LAM). LAM has been demonstrated in a trial in Honduras where women who breastfed 
exclusively for four to six months had longer amenorrhea than those who introduced solid 
foods at 4 months.71 
There is also evidence suggesting that breastfeeding is linked with reduced risk of 
some cancers that affect women. Many studies have demonstrated a protective effect of 
breastfeeding for ovarian cancer;82-84 often the risk reduction due to breastfeeding was 
associated with duration of breastfeeding. Evidence for the effect of breastfeeding on breast 
cancer is however less consistent. In recent studies, breastfeeding either had no effect,85 or 
only had a small protective effect when parity, age at first breastfeeding, and age at 
menopause were controlled.86,87 A recent review of the available evidence concluded that 
women who have a history of breastfeeding had reduced risk of both ovarian and breast 
cancer.88  
Breastfeeding is also associated with greater vascular stress response, lower perceived 
stress levels, and fewer depressive symptoms among lactating women.89 In a study on 
maternal stress and mood, investigators observed that breastfeeding mothers reported lower 
perceived stress than bottle-feeding mothers.90 The same study also reported that 
breastfeeding was associated with a decrease in ‘negative mood’ while bottle-feeding was 
associated with a decrease in ‘positive mood’.  
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In 2001, Nduati and colleagues91 reported the disturbing outcome of a randomized 
trial on HIV progression among Kenyan women. They found a 3-fold elevation in mortality 
among women in the breastfeeding arm of the study compared to women feeding their 
infants with formula. The findings reported by Nduati et al.91 have been criticized for two 
reasons: 1) women who were practicing mixed-feeding were included in the breastfeeding 
group, and 2) almost 50% of women in the breastfeeding arm of the trial had low CD4+ count 
at baseline. The later critique is strengthened by findings of a study by Otieno et al.92 which 
concluded that although breastfeeding was associated with a significant CD4+ decline 
(p=0.01) up to 24 months postpartum, mortality was not significantly different between 
breastfeeding and formula-feeding women. Analyses of data collected among HIV-infected 
South African women did not find an elevated maternal mortality risk due to breastfeeding.93 
Also, a meta-analysis of data from a number of randomized trials also failed to find excess 
mortality due to breastfeeding compared to not breastfeeding among HIV+ lactating 
women.94  
Characteristics and composition of human breast milk 
Human breast milk is a non-uniform fluid with a composition that varies with stage of 
lactation, time of day, stage of feeding at which it is sampled, maternal nutrition, and 
individual differences.95 The first flow of milk after birth is known as colostrum. The onset 
of colostrum secretion is variable but occurs mostly between 38 to 98 hours after birth. 
Colostrum is a thicker fluid compared to mature milk with a creamy or yellowish 
appearance.95 It is exceptionally rich in lipid soluble vitamins, antioxidants, and 
immunoglobulins. However it has less lipid content compared to mature milk. The 
concentration of sodium, chloride, and magnesium in colostrum is higher than mature milk27 
whereas the levels of lactose and potassium are lower.  
Colostrum is important for the establishment of bifidus flora including Lactobacillus 
bifidus. The immunological benefits derived from colostrum are especially crucial for 
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protecting the infant from infections during the immediate postpartum period when the 
immune system is not fully developed. Colostrum gradually turns into transitional milk 
towards the end of the first week postpartum.95 Transitional breast milk has a lower 
concentration of total proteins and immunoglobulins and higher lactose and lipid content than 
colostrum, resulting in an increase in the total energy provided by the milk. By the end of the 
second week postpartum, transitional milk has almost been replaced by mature milk. 
About 90% of mature breast milk is in the aqueous phase.96 Mature milk is packaged 
as emulsified globules coated with a membrane, proteins in colloidal dispersion as micelles, 
and most minerals and all the lactose in true solution.97 Human milk contains all the major 
nutrients, including lipids, proteins, carbohydrates, vitamins, and minerals. The presence of 
immune factors, enzymes, hormones, growth factors, and other bioactive factors makes 
breast milk superior to breast milk substitutes.   
The lipid content of mature human breast milk is about 4% and is considered the most 
variable constituent of breast milk.98 Most of the lipids in breast milk (98%) are present as 
triacylglycerol.96 Other major lipid components in breast milk include cholesterol, fatty acids, 
phospholipids, and sterols. Total lipid content of human milk may be influenced by factors 
including stage of lactation, diet, health status, parity, and gestational age.99 Masters et al.100 
have shown that supplementation with conjugated linoleic acid decreases breast milk total 
lipid content. Breast milk lipids are important as energy stores and as sources of essential 
fatty acids and cholesterol for the infant, and important for promoting intestinal absorption of 
fat-soluble vitamins. The long chain polyunsaturated fatty acids, docosahexaenoic acid, and 
arachidonic acid in human milk have been found to be especially vital in normal neurological 
development,101 development of vision, as well as synthesis of eicosanoids.102  
Milk protein content varies among mammals. In humans, proteins constitute less than 
1% of mature milk content.95 The highest concentration of milk proteins is found in 
colostrum.103 Major proteins in milk include β-casein, albumin, α−lactalbumin, 
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β−lactoglobulin, and immunoglobulins.95 Unlike α−casein in cow’s milk, β−casein in human 
milk is easily digested. Some milk proteins may not provide nutritional benefit, but play 
critical roles as immune factors. Several immunoprotective proteins occur in human milk 
including lactoferrin, lysozyme, secretory immunoglobulin A, epidermal growth factor, and 
interleukin 8.104 Based on their function, these proteins have been classified as either direct-
acting antibacterial factors, anti-inflammatory factors, or immunomodulating bioactive 
compounds.104 Lactoferrin is a glycoprotein with both bacteriostatic and bactericidal 
properties and is found in high concentrations in human milk.105 Lysozyme is capable of 
breaking up bacterial cell walls.106 Interleukin-8 is one of two chemokines found in relatively 
high concentrations in human milk. Interleukin-8 is secreted in response to inflammatory 
activity and plays a role in recruitment and activation of lymphocytes and neutrophils.107 
Interleukin-1 has also been measured in high quantities. During inflammatory conditions 
such as mastitis, high levels of interleukin-8 are secreted into milk.28  
Lactose is the principal carbohydrate present in human milk95 and supplies almost 
half of the energy (40%) available from breast milk. Lactose exerts 60 to 70% of the total 
osmotic pressure of milk and its secretion is accompanied by secretion of large amounts of 
water, making it a key determinant of milk volume.27,108 The quantity of water secreted along 
with lactose is enough to meet the needs of breastfeeding infants without intake of water 
from other sources.109 This finding justifies the recommendation of EBF without giving 
water during the first 6 months postpartum.110 Another osmotic benefit of milk lactose is that 
because it is a disaccharide, its digestion and absorption is less likely to cause postprandial 
osmotic stress. In addition to lactose, other simple carbohydrates present in milk include 
glucose and galactose, both of which are present in relatively small quantities. Breast milk 
contains an array of moderate-chain-length carbohydrates (oligosaccharides and gluco-
conjugates), as well as conjugated carbohydrates including glucoproteins, glycolipids, and 
nucleotide sugars. Some of these carbohydrates protect the gut environment by promoting the 
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growth of lactobacilli, limiting colonization by bacterial pathogens, and inhibiting bacterial 
toxins.111 
The major minerals found in human milk include calcium, magnesium, sodium, 
potassium, phosphorus and chloride.95 Other essential minerals such as iron and zinc are 
found in lesser quantities and their concentration in milk tends to decrease during the first 
four months after birth.5,27 Although the concentrations of iron and zinc in breast milk are 
relatively low, the percentage absorbed is higher among exclusively breastfed infants,112 
compared to those whose receive other foods, because of the high bioavailability of these 
minerals in human milk. Current evidence suggests that the robust homeostatic physiology of 
the lactating woman ensures that the mineral content of her milk is not affected when she is 
deficient in minerals.113 However, maternal iodine and selenium deficiency depletes milk of 
these minerals and maternal dietary intake has been shown to improve the content of these 
minerals in breast milk.114,115  
Adequacy of vitamin supply in breast milk is vitamin specific; generally, breast milk 
vitamin content is sufficient during early lactation.116 With the exception of low vitamin K in 
breast milk, other fat soluble vitamins are supplied adequately by breast milk during the first 
few months postpartum. Breast milk content of most water soluble vitamins are significantly 
affected by maternal status with the exception of folate.113 Vitamin B6 content in milk as well 
as vitamin A has been found to respond to changes in maternal status.  
Enzymes, hormones, and other non-nutritive factors that are especially important in 
neonatal digestion and growth have been assayed in human milk.117,118 These non-nutritive 
components of breast milk play critical roles in modulation of inflammatory processes, 
enhancement of neural transmission, and nutrient synthesis, assembly, and utilization.  
Potentially harmful substances have also been identified in breast milk including 
medication taken by the mother, chemical and radioactive exposures like caffeine, nicotine, 
aflatoxins, and viruses like HIV. Several studies have reported the presence of unusually 
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large amounts of environmental pollutants in breast milk, especially, polychlorinated organic 
compounds.119  
Definition of breastfeeding  
Until 1990, breastfeeding practice was not clearly defined. As a result, there was 
much variation in the indicators used for describing breastfeeding behavior, thus making 
comparisons among studies difficult.120 In 1990, Labbok and Krasovec121 published a 
framework in which breastfeeding behavior was defined to include three broad categories, 
namely: full, partial, or token. Full breastfeeding was described either as ‘exclusive’ or 
‘almost exclusive’. EBF described the practice of feeding infants with breast milk only; no 
other food, drink, vitamin drops, medicines, or water was provided.10 When vitamins, 
minerals, water, juice, or other ritualistic feeds are given infrequently, in addition to breast 
milk, the practice was described as ‘almost exclusive’.122 The term ‘partial’ breastfeeding 
was used to describe the practice of giving other liquid or solid foods to the breastfeeding 
infant. Partial breastfeeding was further categorized as high, medium, or low depending upon 
the proportion of breast milk that constitutes the total nutrient intake of the child. When 
breastfeeding occurred irregularly and for short durations, and essentially to pacify, console, 
or comfort a child, it was described as ‘token breastfeeding’. The WHO later published a 
similar breastfeeding definition framework in which the term ‘complementary feeding’ was 
used to describe any breastfeeding practice that involves giving the infant other liquid or 
solid foods.122  
Global efforts to promote appropriate infant feeding 
Until the past decade, wide disparities existed in breastfeeding practices between 
regions, countries, and even communities within countries. The WHO and United Nations 
Children’s Fund (UNICEF) have championed global efforts to improve infant feeding 
behaviors, especially among developing countries. Some recommendations that were 
instituted to promote optimal infant feeding included the International Code on Marketing of 
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Breast Milk Substitutes, the Innocenti Declaration on the Protection, Promotion and Support 
of Breastfeeding,9 and the Baby Friendly Hospital Initiative.8  
In 1981, the WHO and UNICEF in consultation with governments, professional 
organizations, non-governmental organizations, and the infant feeding industry prepared the 
International Code on marketing of Breast Milk Substitutes that was passed as World Health 
Assembly resolution 34.22.9 The goal of resolution 34.22 was to ensure appropriate 
marketing of breast milk substitutes, feeding bottles, and teats. The code was necessary to 
address the threat posed by marketing of breast milk substitutes to breastfeeding practice. 
The code prohibited promotion of infant formula through hospitals, free distribution of 
formula samples to mothers, and the use of marketing strategies that idealize bottle feeding. 
Most countries have endorsed and have either passed resolution 34.22 into law or are in 
various stages of passing it into law. However, a few countries, including the United States of 
America, Iceland, Chad, and Somalia have taken no action on the resolution.123 The 
International Baby Food Action Network has been monitoring violations of the resolution, 
some of which have been described as substantial violations by major baby food and infant 
feeding bottles and teats manufacturers.124 
In 1990, participants at the WHO/UNICEF policymakers' meeting on breastfeeding 
issued a statement in support of breastfeeding. This statement which became known as the 
Innocenti Declaration recognized that breast milk provides adequate nourishment for infants 
and contributes to their healthy growth and development.9 It also noted that the benefits of 
breastfeeding increased with exclusive breastfeeding during the first four to six months of 
life and, thereafter, breastfeeding with addition of complementary foods. Additionally, the 
declaration urged national health authorities to reinforce breastfeeding culture, protect the 
erosion of breastfeeding culture, and to integrate breastfeeding into overall health and 
development policies. 
17 
 
 
The BFHI was launched in 1991 by UNICEF, with the support of other United 
Nations agencies as a strategy to promote breastfeeding in health institutions. The goal of the 
BFHI was to create an environment that supports breastfeeding in hospitals and free standing 
maternity wards.8 Health facilities designated ‘Baby Friendly’ must prohibit free or low cost 
distribution of breast milk substitutes and must pass an external assessment for the 
implementation of 10 specific breastfeeding promotion steps. Some of the requirements of 
the 10 steps include putting infants to the breast within one hour of delivery, giving newborn 
infants no food or drink other than breast milk (with exceptions when medically indicated), 
practicing rooming-in (that is, allow mothers and infants to remain together 24 hours a day), 
and encouraging breastfeeding on demand.  
The current WHO Global Strategy for infant and young child feeding recommends 
exclusive breastfeeding for the first six months, breastfeeding with complementary feeding 
starting at six months of age, and continued breastfeeding into the second year of life and 
beyond.10 These recommendations were built on the international infant feeding ideals 
described above and were designed to serve as basic guidelines for more comprehensive, 
country-specific approaches to improve infant and young child feeding. The strategy also 
recognizes the important influence of maternal health and nutrition on young child growth 
and urges efforts to address maternal under-nutrition. Specific reference is given to the 
impact of HIV on infant feeding and proposes guidelines to address children in this unique 
situation. 
Current breastfeeding behavior 
Current evidence shows that there has been a positive global response to efforts to 
protect and promote breastfeeding practice. Currently, in many countries where data exist, 
more than 90% of infants are introduced to breast milk.11,125 The greatest improvements in 
breastfeeding initiation have been reported in Europe and North America where 
breastfeeding initiation rates were previously very low.  
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The push for EBF of infants during the first few months postpartum has also yielded 
positive results. Between 1990 and 2000, EBF increased marginally in all regions of the 
world.126 East Asia and Pacific regions recorded the highest rates of EBF.  However, the 
greatest improvement in EBF was observed in the Sub-Saharan Africa region, which together 
with the North Africa and Middle East regions, currently, have the lowest regional EBF rates 
(34%). Within countries, there were greater improvements in EBF among urban rather than 
rural dwellers.  Despite these improvements, EBF rates still remain low globally; only 39% 
of infants less than six months are EBF.12  
Challenges to breastfeeding 
Although the ability to breastfeed successfully comes naturally to many women, 
especially in cultures where breastfeeding the newborn is the norm, there are also many 
women who need support in order to breastfeed successfully. Young and first time mothers, 
especially, need expert support to overcome problems that affect their ability to breastfeed 
successfully. The source of breastfeeding problems may be attributed to cultural and 
socioeconomic factors such as maternal education, where the baby was delivered, availability 
of alternative infant feeds, lack of social support, misperceptions about breastfeeding from 
spouse, family, or friends, as well as the prevailing infant feeding practices in the community 
that may discourage breastfeeding practice.127,128 Breastfeeding problems that derive from 
biological factors may include breast pain, sore nipples, breast swelling, and congenital 
defects that limit the ability of the infant to suckle effectively. Psychological barriers to 
breastfeeding include peer conformity pressure and the belief of ‘inability to produce enough 
milk’.13,14 
Subclinical mastitis  
SCM is a common asymptomatic inflammatory condition of the lactating breast and 
has only recently been clearly characterized in the human lactation literature.22 Interest in 
SCM has grown because of its association with elevated risk of HIV transmission from 
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mother to child through breast milk.24,25 SCM may occur for several reasons including 
localized inflammation of mammary tissue resulting from milk stasis,129 localized breast 
infection, physical breast tissue trauma,26,27 mammary gland involution due to reduced breast 
milk production,27 micronutrient deficiency,28,29 and systemic infection.30 Poor lactation 
practices and weak suckling by the infant have also been associated with SCM.27,31 The 
mammary tissue inflammation occurring during SCM leads to involuntary opening of the 
tight junctions cementing alveolar cells. The result is a net leakage of inflammatory cells and 
other plasma components, including sodium and chloride ions, into breast milk.32,33,34 
Simultaneously, there is efflux of potassium ions from milk spaces into interstitial spaces to 
maintain ionic balance.  
SCM may progress to clinical mastitis that is diagnosed with symptoms of fever, 
breast pain, reddening of affected breast area, and engorgement of the breast.95 Clinical 
mastitis, unlike SCM, has been studied more extensively and has been associated with factors 
that affect ineffective emptying of the breast, including persistent breastfeeding from a 
preferred side of the breast, weaning, wearing tightly fitting brazziere/clothing,130,131 use of 
pacifiers,132 and a prone sleeping position.133 The role of poor hygiene and infection in the 
causation of clinical mastitis has also been reported. 134 
Subclinical mastitis epidemiology 
Bilaterally elevated breast milk sodium is typical of early lactation and usually 
becomes reduced by the 14th day postpartum.34 The subsequent unilateral elevation in breast 
milk sodium, however, is persistent and occurs in response to mammary inflammation. High 
prevalence ranging from 12% to 25% during the first 14 weeks postpartum has been reported 
in different settings.24,37,44 For example, a study in Bangladeshi women has shown that 25% 
and 12% of healthy breastfeeding women had elevated sodium:potassium ratios at 2 weeks 
and 3 months postpartum, respectively.36  
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Another study that diagnosed SCM using elevated breast milk sodium reported a 
prevalence of 16% among HIV-infected women in Malawi at six weeks postpartum; the rate 
reduced to 3% by the 6th month postpartum.25 Some studies have reported that markers of 
SCM may be observed even at 12 months postpartum.39 Studies by Dewey et al.31 have also 
reported that the weaning period was associated with elevated breast milk sodium content.  
Assessing subclinical mastitis 
In human studies, SCM has commonly been diagnosed as elevated breast milk 
sodium,25 sodium-potassium ratio (Na/K),24,37,135 somatic cell count,136 or Interleukin-8.28 
Inflammation of mammary tissue triggers a series of physiological changes that eventually 
results in the elevation of breast milk sodium ion and chloride ion concentrations as well as a 
decline in potassium ion concentration.32,33 These changes form the basis for the use of milk 
sodium, Na/K or electrical conductivity as markers of SCM. Na/K, rather than sodium 
concentration alone is commonly used for SCM diagnosis because: 1) it is assumed that the 
ratio of sodium to potassium will control for assay variations that may occur due to unequal 
distribution of the ions in the aqueous and lipid phases of milk and 2) the ratio accounts for 
the normal and almost parallel decline in both sodium and potassium ions during early 
lactation.5  
Normal human milk sodium and potassium concentration are tightly regulated and 
range between 5 to 6 mmol/L and 13 to 14 mmol/L respectively.5,34,137 Adcock et al.138 have 
noted, however, that there is a gradual decline in breast milk electrolyte concentration over 
time postpartum. The highest sodium concentration has been observed in colostrum. The 
reported extremes for sodium in human milk are a low of 2 mmol/L and a high of 94.6 
mmol/L.139,140  
Part of the variation in the reported sodium or potassium concentration is due to the 
different assay methods used including flame photometry, atomic absorption/emission 
spectroscopy,24,28,37 and ion-selective electrode methods.4,34 The procedures used in flame 
21 
 
 
photometry and atomic emission spectroscopy are well established and are considered 
standard methods.141 However, ion-selective electrode methods allow for rapid and 
inexpensive analysis of large number of samples. 
 In the study reported by Semba4 in Malawi, SCM was diagnosed when sodium 
concentration was above 12 mmol/L. About 16% of the 96 lactating women in the study were 
diagnosed with SCM at six weeks postpartum. In an earlier study, Morton35 had screened 
women with lactation problems using sodium concentration of 16 mmol/L as the diagnostic 
threshold. When Na/K is used for SCM diagnoses, ratios below 0.6 are considered normal. 
Na/K between 0.6 and 1.0 are described as moderately elevated while Na/K > 1.0 is 
considered severely elevated.24,37,44 These cutoffs were selected based partly on the 
distribution of Na/K and also on published levels of sodium and potassium in the available 
literature. Willumsen et al.44 have argued that Na/K > 1 is equivalent to 18 mmol/L of 
sodium which is indicative of mastitis after the first few days postpartum and in the absence 
of weaning.  
In dairy cows, the primary cause of mastitis is bacterial infection, with 
Staphylococcus aureus identified as the most common pathogen.142 Bacterial infection leads 
to inflammation in the mammary tissue similar to mastitis in human mammary inflammation. 
Bacterial cultivation is therefore considered the ‘gold standard’ for diagnosing mammary 
infection.143 However, other methods have been developed for diagnosing mammary 
infection including electrical conductivity,144 somatic cell count,145,146 and the California 
mastitis test (CMT).147  
Subclinical mastitis, infant feeding, and growth 
A few studies highlight the association between infant feeding practice and SCM. 
Aperia et al.137 have reported elevated breast milk sodium in clinical situations where 
ineffective breast emptying occurred on or before the first three days postpartum. They noted 
that a high sodium content in breast milk was related to potential lactation failure that was 
22 
 
 
reversible with effective breast emptying using breast pumps. Willumsen et al.44 have also 
reported that SCM was more prevalent among mothers who practiced mixed-feeding 
compared to EBF, especially during the first few days postpartum.  
Morton35 has reported that infants in the United States whose mothers had elevated 
breast milk sodium concentration (> 16 mmol/L) gained less weight within the 3rd and 8th 
days postpartum. This finding has been replicated among mother-infant pairs recruited into a 
vitamin A trial in Bangladesh.36 In this trial, low weight gain was significantly associated 
with elevated breast milk IL-8 content. IL-8 is a marker of SCM and has been found to be 
significantly correlated with Na/K. Currently, the mechanism relating SCM with infant 
growth faltering remains undefined. 
 In the dairy cows, SCM is associated with decreased milk production.148 In beef 
cattle, it has been reported that calves nursed by cows with SCM experience a significant 
decrease in weight gain.40 Lents et al.149 have reported that the effect of SCM on calf weight 
was limited to early lactation, but disappeared by weaning age. Kirkbride41 had reported that 
growth faltering in calves could be reversed with mastitis treatment. However, the study by 
Lents et al.149 failed to observe this outcome. A recent study by Dahl et al.150 reported that 
among 3 week post-parturition dairy cattle, frequent milking led to increased milk volume 
and decreased milk cell count. These studies suggest a number of outcomes due mammary 
inflammation: 1) SCM may be associated with a decline in the ability of the mammary 
epithelium to produce enough milk and 2) increased milk output with frequent milking may 
lead to better flushing of pathogens out of the gland. Poor growth outcomes in the beef calves 
may be due to avoidance of nursing by the lactating cow due to pain or by the calf due to 
changes in milk flavor or composition. Frequent milking can increase milk output as well as 
relieve mammary inflammation and hence increase the supply of milk to the calf. A similar 
mechanism may be occurring in human lactation although no evidence from human studies 
currently exists. Prentice et al.26 have reported that clinical mastitis in the human breast may 
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be associated with destruction of secretory mammary tissue with adverse consequences for 
subsequent lactational performance. 
Another mechanism that may explain infant growth faltering as a result of maternal 
SCM is decreased milk acceptability by the infant that translates into decreased milk intake 
(Figure 2.1). Conner42 has reported the case of an infant who preferred the sweet tasting milk 
produced by the mother’s normal breast compared to ‘salty’ milk produced from the other 
breast that had elevated sodium. In such a situation, reduced emptying of the affected breast, 
from which the infant feeds less frequently, will lead to reduced milk output.150 The bulk of 
the infant’s breast milk intake come from the unaffected breast. Whether the unaffected 
breast alone is capable of producing enough milk to meet the nursing demands of the infant 
depends upon the ability of the mother to practice breastfeeding behaviors that increase her 
milk supply. However, studies have shown that when mothers have concerns about low milk 
supply, they are likely to introduce other foods, which will further decrease milk intake, or 
wean their children.16,17  
Control of subclinical mastitis 
Animal studies have demonstrated a protective role of micronutrients including 
selenium and vitamin E against SCM.29,151 Similarly, studies in rural Tanzanian women have 
demonstrated a reduction in SCM in response to vitamin E-rich sunflower oil but not to 
vitamin A-rich palm oil supplementatin.28 Another trial in Zimbabwe showed a non-
significant decrease in the prevalence of subclinical mastitis among HIV-positive women less 
than 4.5 months postpartum who were receiving multivitamin supplementation according to 
the U.S. dietary recommended intakes (DRI).37 
A possible mechanism for the protective role of micronutrients is to decrease the 
inflammatory cytokines as well as the tissue damage resulting from free radicals that may be 
produced during inflammation.44,152 In a recent micronutrient trial, pregnant women in Nepal 
were assigned to receive either routine iron and folate supplements or multi-micronutrient 
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tablets containing 15 micronutrients.153 This study did not find any effect of multiple 
micronutrient supplementation on the contents of Na/K in breast milk collected at one month 
postpartum.  
Flores and Filteau21 have reported a non-randomized trial among Bangladeshi women 
in which the intervention group participated in a single lactation counseling session with a 
trained counselor. Counseling sessions were carried out any time around delivery (antenatal, 
on day of delivery or postnatally) and covered topics including the importance of giving 
colostrum, good positioning and attachment, importance of breastfeeding soon after birth, 
feeding on demand, and the need for breastfeeding exclusively for 4-6 months postpartum. 
At four weeks postpartum, women who had received lactation counseling had significantly 
lower geometric mean Na/K (14%) than those in the control group who did not have any 
counseling. Since this study was published, there have been no reports confirming the 
outcome of this study in the same or other populations. The efficacy of this intervention also 
needs to be tested in a randomized experiment to establish its application in the control of 
SCM. 
A recent study in Malawi136 assessed the effect of antibiotics on reducing breast milk 
HIV viral load by reducing SCM. Seventy-five HIV-1 infected women who were diagnosed 
with subclinical mastitis (leukocyte count > 106 cells/ml) at two weeks postpartum were 
treated with oral amoxicillin/clavulanic acid. The women were followed up at scheduled 
clinic visits during which milk samples were collected to assess SCM status. After one week 
post treatment, leukocyte count had declined significantly (p < 0.001) by more than 58%. 
However, there was a non-significant increase in breast milk sodium at the same time. 
Further leukocyte decline was subsequently observed between the 4th and 12th week post 
treatment (p < 0.001), and at this time, the leukocyte decline was accompanied by a 
significant decline in sodium concentration (p < 0.05). The outcome of this study was in 
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agreement with the use of antibiotics in the reduction of mammary inflammation in clinical 
mastitis.154  
Milk biosynthesis, secretion, and regulation 
The functional milk secreting unit of the mammary gland is the alveolus. Milk 
components are synthesized in the mammary gland by a single layer of epithelial cells lining 
the alveoli.155 The content of the alveoli are drained by a network of ducts that export milk 
from the site of production to the nipple through which milk exits the breasts. The alveoli are 
surrounded by myoepithelial cells that provide the contractile force needed to expel milk 
from the alveolar lumen. A rich supply of capillary tissues and fat cells that surround the 
alveoli together provide the substrate needed for milk synthesis.  
Substrates required for milk synthesis originate from circulating blood and may reach 
milk ducts by two main routes: 1) a trans-cellular pathway which allows substrates to be 
transported across both the basolateral and apical membranes of the alveolar cell into milk 
ducts and 2) a para-cellular pathway that allows substrates to ‘leak’ through extra-cellular 
spaces. Alveolar epithelial cells, however, are connected to each other by apical junctional 
complexes (adherens) and tight-junctional elements that inhibit exchange of substances 
between vascular and milk compartments via para-cellular pathways.156 The para-cellular 
pathway thus becomes functional only under certain physiological conditions that will be 
discussed subsequently. 
Milk secretion into alveolar ducts involves five distinct pathways based on the 
chemical structure of the substrate. Endogenously generated milk proteins are primarily 
secreted by the exocytotic pathway.155 Other milk components including water, lactose, 
oligosaccharides, phosphate, calcium, and citrate are secreted by this pathway.  Similar to 
other exocytotic secretion mechanisms, these milk components are packaged into membrane-
coated secretory vesicles. The vesicles move to and become attached to the apical membrane 
of the alveolar cell where its contents are subsequently released into the milk duct. A trans-
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cellular pathway has also been suggested for the secretion of some proteins including 
immunoglobulin A into milk.157 This pathway is accomplished by endocytosis and exocytosis 
at the basolateral and apical membranes, respectively. Trans-cellular secretion of prolactin, 
transferrin,158 and low-density lipoprotein into milk have been reported.159 
Using substrate from fat cells and circulating plasma lipids, milk lipids are 
synthesized in alveolar cells, which have a well developed lipid synthesis capacity. Milk 
lipids are secreted as protein coated lipid droplets. These droplets subsequently coalesce with 
the alveolar apical membrane and are discharged into the milk duct as milk fat globules in a 
unique budding process described by Mather and Keenan.160 
Solute-specific membrane secretion pathways exist for ions, glucose, and amino acid 
transport and involve specific transporters located at both the basolateral and apical 
membranes of the alveolar cell.155  While transporters for sodium, potassium, and glucose 
have been identified on both the alveolar cell’s basolateral and apical membranes161,162, only 
basolaterally located channels have been described for calcium and amino acids.163 At 
present, it is not entirely clear how calcium and amino acids are secreted into milk. This 
pathway has also been associated with secretion of certain drugs into milk.164 
The paracellular pathway is associated with bi-directional transfer of both low and 
high density milk components into and out of milk spaces. This pathway is typically closed 
during established lactation among humans and other mammals by tight junctional 
complexes.155 The tight junctions may become leaky during pregnancy and in lactation as a 
result of mammary inflammation. Solutes such sodium, chloride, and to a limited extent 
magnesium and potassium are secreted at a higher concentration towards the end of 
pregnancy and during the first few days postpartum, prior to the closing of the tight 
junctions.27 A similar process occurs during the weaning period that triggers mammary 
inflammation, resulting in increased milk concentration of sodium and protein.  
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Regulation of milk secretion 
Milk secretion is a highly regulated physiological function. Hormonal regulation of 
mammary tissue is initiated during puberty.165 During early pregnancy, estrogen, 
progesterone, prolactin 166,167 and also growth hormone168 regulate mammary tissue 
preparation for secretory activity by influencing ductal proliferation and alveolar tissue re-
organization. The onset of milk secretion at birth is however regulated by a decrease in 
progesterone169 in the presence of appropriate quantities of prolactin and cortisol170 just 
around parturition. The decrease in progesterone serves as a trigger for the closure of the 
tight epithelial junctional complexes that limit para-cellular transport pathways.170 While 
there is incomplete understanding of the hormonal control of all individual milk solutes, 
prolactin has been linked with survival of alveolar cells, maintenance of epithelial junctions, 
synthesis of milk proteins and lactose as well as the transport of several milk components 
including iodide,171 some amino acids172,173 and glucose.161  
The individual milk components are assembled in the alveolar ducts to form milk 
during the onset of lactation. Milk ejection from the breast is triggered by suckling stimulus 
of the infant on the areola, which in turn stimulates oxytocin release. Circulating oxytocin 
causes the myoepithelial tissue surrounding the alveolar cells174,175 to contract for milk 
ejection to occur. Hence, termination of the suckling stimulus can lead to milk stasis and 
eventually mammary tissue involution.  
Once lactation has been established, local factors become involved in regulating the 
rate and amount of milk secreted.176 Infant demand has been shown to be an important 
regulator of milk secretion.177 The mechanism for control of milk secretion by infant appetite 
is explained by the strong association between the rate of milk secretion and the extent of 
breast emptying, breast storage capacity, and variations in the short-term rates of milk 
synthesis.43,178 As a consequence, introduction of complementary food leads to a reduction in 
the amount of milk secreted.  
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Studies by Daly et al.43 indicate that the capacity of the mammary gland to produce an 
adequate amount of milk for the infant is independent of either breast size or total milk 
storage capacity. Hence, women with small or large breast sizes are capable of breastfeeding 
their children successfully. It has long been known that children of small-breasted women 
were able to meet their daily milk requirements by increasing their milk intake frequency.179 
It has also been suggested that an autocrine mechanism may be responsible for the 
short-term regulation of milk secretion. Studies in goats have suggested that feedback 
inhibitor of lactation (FIL) may be responsible for the local control of milk secretion.180-182 
FIL is a small whey peptide, produced by the mammary epithelium and has been shown to be 
sensitive to changes in the volume of the mammary gland without effecting significant 
changes in the composition of the milk secreted.182 FIL content increases and acts in a 
negative feedback mechanism to reduce milk synthesis when the mammary tissue is filled 
with milk. On the contrary, when mammary tissue is emptied, FIL concentration is reduced 
to increase milk synthesis. 
Typically, the 24-hour milk output increases from onset of lactation until it reaches a 
fairly constant volume of about 800 ml among exclusively breastfeeding women, at six 
months postpartum.183 Variations in milk output across women may be attributed to both 
behavioral and biological influences. The most common complaint of women who have 
problems with breastfeeding is inadequate milk output.13,14 Several other factors have been 
associated with lactation failure. In a study among low income Mexican women, lack of 
confidence in breastfeeding, delayed onset of milk production, poor maternal education, 
multiparity, sore nipples, early introduction of formula to the previous child, and the mother 
having been breastfed as a child were factors that were significantly associated with 
perceived insufficient milk.17 Menella and Beauchamp184,185 have reported a 20% decrease in 
infant breast milk consumption within the 3-4 hours following alcohol consumption. 
Menella186 has also observed a decrease in milk intake after alcohol consumption without 
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alteration of milk quality. Moderate to heavy smoking is also associated with reduced milk 
secretion.187   
Assessment of breast milk synthesis and infant intake 
Test weighing is traditionally used to assess adequacy of infant milk intake.188 Test 
weighing involves determination of the difference in infant weight before and after 
breastfeeding as an indication of infant milk intake. The accuracy of this method assumes 
that the losses in weight due to crying, insensible water loss through sweat, and spillage of 
milk during feeding are either minimized or considered in the analyses.178 Typically, test 
weighing is carried out over a period of 24 hours to account for the variation in both milk 
intake within a day and the between-feed duration.  
The advantage of test weighing to the assessor is that it involves a fairly simple 
procedure for measuring the weight of the infant just before and after breastfeeding. The use 
of test weighing is however associated with inherent difficulties. Test weighing is considered 
to be incapable of distinguishing between the ability of the infant to consume milk and the 
mother’s ability to synthesize the same.188 Savenije and Brand189 have argued that although 
test weighing is an accurate procedure, its precision is low and even more so in situations 
where breastfeeding frequency is high and milk intake per feed is low. Test weighing is 
therefore not recommended for assessment of breast milk intake in clinical situations.  
Furthermore, test weighing imposes an intrusion on the breastfeeding demand-and-
response cycle occurring between the infant and mother. To reduce these intrusions, some 
studies have estimated breast milk intake using abbreviated test weighing methods that use 
12-hour rather than 24-hour observations.190,191 While Brown et al.192 have reported that 
breast milk intake between 6 am and 6 pm among Bangladeshi infants accounted for 46–58% 
of the 24-hour total intake, Matheny and Picciano190 found that more than half of the daily 
intake was consumed within the same period among American infants.  
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An indirect test weighing procedure that involves weighing both the mother and 
infant before sleep and in the morning, to avoid the inconvenience of night time 
measurements, also has proved inadequate.190 Breast milk intake has also been assessed using 
stable isotope (2H2O, 2H218O) dilution methods in either the mother or infant. While dilution 
methods allow unobtrusive measurement of milk intake, it is unsuitable for short-term 
assessment of milk intake.193 Other less obtrusive methods that have been used for milk 
intake assessment are the swallow counter which is useful for assessing the pattern of short-
term milk transfer194 and the flow meter that consists of a miniature ultrasound flow 
transducer fitted into a nipple shield to measure the rate of milk transfer.195  The flow meter, 
however, is considered to be less accurate in measuring milk intake compared to test 
weighing.196 
To assess milk synthesis, researchers in Australia have developed methods that 
involve the measurement of breast volume using topographic technologies. These methods 
measure the increase in breast volume from the end of one breastfeed to the beginning of the 
next. A measure of the mother's short-term rate of milk synthesis is then estimated as the 
ratio of change in breast volume to the duration between breastfeeds. Arthur et al.197 have 
described a method for measuring short-term milk synthesis known as Moire topography. 
The process involves illumination of the breast by passing a light source through a special 
grid that creates a ‘Moire’ effect. Photographs of the images created on the breast are 
captured to create a three-dimensional topograph of the breast that is then used to estimate 
breast volume. The precision of this procedure depends on the ability to re-position the breast 
between measurements. The performance of the method also falters with larger breast sizes. 
The data processing for this method was rather slow, making it impractical for larger sample 
sizes. 
Subsequently, the computerized breast measuring system (CBM) was developed and 
successfully used to assess the rate of short-term milk synthesis.43 The CBM uses a 
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computerized system to analyze video images of the breast upon which structured light 
patterns have been projected to create counters. The CMB overcomes the limitations of the 
Moire topography method by including features that minimize breast re-positioning 
deviations. The data created can also be analyzed more rapidly. Despite the potential utility 
of the CBM, it is currently an expensive technology that is not yet available to many research 
laboratories.  
Infant growth and childhood malnutrition 
Nutritional status of children is commonly assessed using weight and length 
measurements.198,199 In emergency situations where rapid assessments are needed, mid-upper 
arm circumference (MUAC) has been found useful.200 Traditionally, indices computed from 
anthropometric measurements have also been used to report populations at risk for 
malnutrition.201 Three anthropometric indices that are commonly used to assess infant and 
child growth status are length-for-age, weight-for-age, and weight-for-length.202 To 
determine the nutritional status of children, these indices are compared with a reference 
population. The use of a reference population allows comparison of child growth in different 
age and gender groups.  
Until recently, the National Center for Health Statistics (NCHS)/WHO reference 
population was used in most countries.201 This reference was generated using data collected 
from North American Caucasian children who were largely bottle-fed rather than breastfed 
and were measured at 3 month intervals.203 The characteristics of the reference population 
were considered inappropriate as a reference for the optimal growth of children elsewhere, 
whose mothers are encouraged to practice EBF during the first six postpartum.204  
In 2006, the WHO published new child growth standards.205 Data for the new growth 
standards were obtained from six multi-center surveys covering a wide diversity of ethnicity 
and socio-demographic backgrounds. Unlike the growth references that were in use 
previously, the new WHO standards adopt a prescriptive approach that defines how children 
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‘should’ grow rather than ‘how they grow’ within the influences of their environment.206 As 
expected, important differences have been observed when the growth patterns of the same 
children were compared using either the WHO growth standards, the NCHS/WHO 
references, or the CDC references.205,207 Some of the differences were limited to specific 
growth indicators. Differences were also attributed to the overall nutritional status of the 
population being studied as well as the specific age group that was studied. For instance, the 
prevalence of low weight-for-age was higher when estimated using the WHO standards 
compared to either the NCHS, or the CDC references.205,207 
Comparison to a reference population is made using either the z-score, percent of the 
median, or percentiles of the growth indices.208 The z-score is considered a better indicator of 
physiological changes underlying growth than percentage of median or percentiles. The 
WHO recommends the use of the z-score by its member countries for the assessment of 
growth deficits.209 The z-score is computed as the ratio of the deviation from the median of a 
reference population of the same age and sex, to the standard deviation of the reference 
population. A z-score less than -2.0 standard deviations is conventionally used as the 
threshold below which children are considered to have growth deficit. This cutoff is useful 
for identify the children most at risk of adverse child outcomes. It is important to note that 
the cut-off for z-scores is arbitrary and is should be determined based on the purpose for 
which it is to be used. For example, in emergency situations where there are limited 
resources, a more stringent cut-off such as z-score of 3.0 may be used to identify infants most 
at risk of mortality.  
A low length-for-age z-score, described as stunting, is indicative of long-term under-
nutrition and reflects retardation in skeletal growth.201 Weight loss or a failure to increase 
body mass due to recent under-nutrition and/or disease is indicated by a low weight-for-
length z-score (i.e. wasting). Weight-for-age (underweight) is commonly used as a screening 
tool in emergency situations because it does not involve the measurement of height or length. 
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However, interpretation of weight-for-age is less useful compared to length-for-age and 
weight-for-length because a low weight-for-age may result from either acute or chronic 
malnutrition or both. Compared to length-for-age, weight-for-age and weight-for-length have 
been shown to underestimate long-term malnutrition.209  
In the year 2000, the WHO global database on child growth and malnutrition reported 
stunting in about 30% of all children less than five years of age in developing countries.210 
Stunting was most common in East Africa (44.4%) and South-Central Asia (39.7%). With 
the exception of Sub-Saharan Africa, there was a consistent downward trend for stunting in 
all developing countries between 1990 and 2000. Latin America and the Caribbean region 
had the lowest level of stunting (13.7%). In the same analyses, comparatively less 
underweight as compared to stunting was found in all regions of the world. About 22% of 
children below five years were found to be underweight globally. In developing countries, 
however, underweight was reported among 25% of children. About 74% of all underweight 
children, a total of 101 million, were residing in Asia. Of this number, about 72% were in 
South-Central Asia. The prevalence of wasting in developing countries was 9%. The highest 
prevalence of wasting was observed in West Africa (15.6%) and South-Central Asia 
(15.4%).202 These measures of growth serve as useful indicators of child well-being and 
development.211 
Outcomes of poor infant growth 
There is strong epidemiologic evidence supporting the relationships between poor 
growth and a number of human development outcomes including delayed mental 
development,212 poor school performance and reduced intellectual achievement,213 functional 
impairment in adult life211, and reduced work capacity.214  
Prevalence of wasting above 5% in a population is often associated with substantial 
increases in mortality.211 Analyses of community-based longitudinal studies have 
demonstrated that about 46 and 80% of death among children result from mild-to-moderate 
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malnutrition.215 The commonest causes of preventable deaths in children below 5 years 
include pneumonia (19%), diarrhea (18%), measles (4%), malaria (8%) and neonatal 
conditions (37%) such as preterm birth, infections and birth asphyxia.216 Yet, about 61% of 
diarrhea, 57% of malaria and 53% of pneumonia is attributed to being underweight. 
The UNICEF framework on malnutrition identifies behavioral and environmental 
factors that increase the risk of infant morbidity and mortality217 including inadequate access 
to food, poor child feeding practices, access to health services, availability of potable water 
and other utility services that are associated with disease prevention. The effect of these 
factors are often made worse by household and socio-economic factors that include poor 
maternal education status, low household incomes, large household sizes, poor child care 
practices, and harmful cultural practices.218  
Determinants of poor infant growth 
Infectious diseases and poor nutrition constitute the primary determinants of growth 
faltering among children in developing countries.217 The World Bank in 1993 attributed 
between 20 and 25% of the global burden of disease in children to undernutrition. Other 
researchers have made projections that suggest that malnutrition may even account for as 
much as 50% of the global burden of disease.219 The interactions between inadequate dietary 
intake and infectious diseases create a vicious cycle that ultimately overcome the child’s 
immune system.202 A poor micronutrient status has been shown to correlate with poor growth 
in children. For instance, zinc deficient children have a 13 to 21% elevated risk of dying from 
diarrhea, pneumonia, and malaria.220 Perhaps the greatest impact of malnutrition on infant 
survival is the increased risk of case fatality.  
The direct determinants of poor nutrition among children under five years have been 
identified as low prevalence of exclusive breastfeeding, delayed initiation of breastfeeding, 
introduction of complementary feeding before six months postpartum, delayed introduction 
of complementary feeding beyond six months postpartum, feeding foods with low energy 
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and nutrient density.10,221,222 Several studies have demonstrated clearly that timely initiation 
and practice of exclusive breastfeeding during the first few months postpartum are associated 
with optimal growth outcomes in children.223 Attachment to the breast as early as possible 
after birth as was well as timely introduction of complementary feeding just after the child 
becomes six months old are considered appropriate infant feeding behavior. Long-term 
intake of inadequate diets is associated with several outcomes of poor health and growth 
faltering in children, by compromising immune response and consequently increasing the 
risk and severity of infections.224  
Deficiency of most nutrients have an effect on lowering immunity, giving way to 
increased incidence, severity, and duration of diseases. For example, vitamin A deficiency 
affects epithelial membranes and potentiates diarrhea and respiratory tract infections.225 
Although the results of high dose vitamin A supplementation trials have not yielded 
conclusive outcomes, it appears that the incidence of both diarrhea and lower-respiratory-
tract infections may be lowered by vitamin A supplementation.226,227 Other studies have 
shown that children with protein-energy malnutrition have increased episodes and duration of 
diarrhea.228 Most diseases also reduce appetite and food intake, causing further weakening of 
the immune system and perpetuation of the vicious cycle.  
Complementary feeding 
Breast milk alone becomes inadequate to meet the nutritional needs of growing 
infants and it is recommended that complementary feeding start by the sixth month after 
birth.10 Typically, non-human milk, semi-solid or solid foods are provided as sources of 
nutrients to complement nutrients that are obtained from breast milk.229 Decades of studies in 
poor income settings show that the period of complementary feeding, especially the period 
between six and 12 months after birth, is associated with significant infant growth faltering 
and susceptibility to gastrointestinal and respiratory infections.230  
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It is thought that the adverse growth outcomes observed during the period of 
complementary feeding can be attributed to a number of related factors including caregivers’ 
ignorance of appropriate complementary foods, how much food should be given to the infant, 
and the frequency of feeding.202 The nutritional quality of the food is a key component of 
current definition of optimal complementary feeding. Analysis of complementary foods in a 
number of developing countries indicates a low level of lipids and micronutrients, especially 
zinc, iron and vitamin B6.229 The methods employed in food preparation and the way in 
which it is presented to the child also constitutes an important risk factor for inadequate 
complementary feeding. Additionally, feeding frequency, scheduling of feeding, as well as 
the environment in which the feeding process takes place, constitute other factors that are 
used to judge the adequacy of the complementary feeding process. 
Dietary characteristics including energy density, sweetness, and viscosity have been 
found to affect the amount of complementary food intake among young children.231 Because 
children tend to consume more food if it tastes sweet and are presented in a less viscous 
matrix, there have been efforts to study the effects of promoting these characteristics in 
complementary foods. Bennett et al.232 have demonstrated that the use of the enzyme, 
amylase, to promote liquefaction of high density and high viscosity porridge resulted in 
increased daily energy intake among Peruvian children.  
Intake of complementary foods is also influenced by the child’s appetite. Childhood 
morbidities like diarrhea and malaria can lead to a loss of appetite and hence a reduced intake 
of complementary foods. It is estimated that diarrhea may reduce the intake of 
complementary foods by up to 30%.233 It has also been reported that zinc deficiency is 
associated with impaired taste and smell sensations and may depress appetite in children.234  
Physiological characteristics of the child during this early stage of life may also limit 
optimal intake of complementary foods. For instance, the small gastric capacity of infants 
37 
 
 
limits the total amount of food that can be consumed at each feeding event. Thus infants may 
require frequent feeding to meet their nutrient needs.  
Caregiver interaction, encouragement, and responsiveness during infant feeding in a 
non-distracting environment are associated with increased total intake of complementary 
foods. Studies among Bangladeshi children found that responsive feeding behaviors may 
include active physical help and verbalization during feeding. Role-playing and persistence 
were associated with higher rates of food acceptance.235 On the other hand, lack of 
responsive feeding behaviors led to more frequent rejection of food by the infant. The 
realization of improved infant well-being through improvements in infant feeding behaviors 
depends on the ability of caregivers to adopt these positive infant feeding behaviors. 
HIV/AIDS and infant feeding 
In addition to the commonly known infectious diseases that threaten infant and young 
child well-being, HIV and Acquired Immune Deficiency Syndrome (AIDS) constitute a new 
challenge to global efforts to improve maternal and child nutrition and health. HIV/AIDS 
was first observed in 1981236 and has since become the most challenging public health 
problem in modern history. At the end of 2006, an estimated 39.5 million people were living 
with HIV/AIDS globally of which 2.3 million are children less than 15 years of age.237  
Most HIV infection occurs in low income countries. Sub-Saharan Africa is home to 
24.7 million people infected with HIV, representing more than 60% of all infections.237 In 
2006 alone, an additional 4.3 million people were diagnosed with HIV of which 530,000 
were children below 15 years. Currently, almost 22% of all HIV infected persons live in 
Asia. HIV/AIDS is the leading cause of mortality worldwide for adults aged 15-59 years. 
AIDS has so far resulted in the death of about 26 million people; 2.9 million of AIDS 
mortality occurred in 2006 alone.237 One out of every eight deaths due to HIV/AIDS 
involved a child less than 15 years old in 2006.  
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 Poverty serves both as a determinant and an outcome of HIV. Among low income 
populations, high risk behavior is frequently practiced, in some cases dictated by food and 
livelihood insecurity. These high risk behaviors coupled with a compromised ability to 
negotiate safe sex lead to increased risk of infection.238 Vulnerable groups, like women and 
sexually active adolescents have higher risk of infection. Elevated rates of infections are also 
found in high risk groups including commercial sex workers, men who have sex with other 
men, and intravenous drug users. 
HIV and challenges to infant feeding  
The major mode of HIV transmission for both men and women continues to be 
unprotected heterosexual relations.237 Transmission may also occur through blood 
transfusions, intravenous drug usage, use of unsterilized invasive clinical equipment, and 
breastfeeding. The presence of HIV in breast milk was first reported by Thiry et al.239 
Subsequent studies confirmed this finding and also demonstrated clear evidence of HIV 
transmission via breast milk.240 Other studies later found elevated risk of transmission among 
breastfeeding compared to formula feeding infants.241 Mother-to-child transmission (MTCT) 
of HIV can occur via three pathways: placental transfer during pregnancy, mucosal transfer 
during delivery, and post-natally through breastfeeding. 
Maternal factors that promote MTCT of HIV include elevated maternal plasma viral 
load that is a characteristic of primary infection, low CD4+ (< 400/mm3), failure to receive 
anti-retroviral therapy during pregnancy, maternal nipple lesions, and mastitis.242 Among 
infants, oral thrush, prolonged breastfeeding, and inflammation of the gastrointestinal tract 
possibly resulting from mixed feeding may increase the risk of HIV transmission.243 An 
estimated one-third worldwide 244 and one-half in Africa241,243 of all MTCT of HIV and are 
due to breastfeeding.  
Determination of the route of HIV transmission in infants is complicated by 
difficulties in determining the timing of infection. Early antibody tests developed for HIV 
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testing in infants were incapable of differentiating between infant and maternal antibodies 
during the first 12 months postpartum. Even with the use of polymerase chain reaction (PCR) 
techniques, HIV tests can be reasonably determined only after one month of age.245 It has 
also been reported that the risk of transmission via breastfeeding is twice as high for women 
infected before or during pregnancy.246 This is because initial infection is associated with 
high viral load.  
Several studies have reported that risk of HIV transmission through breastfeeding 
may continue as long as the child is breastfed.94,247 The use of advanced analytic techniques 
in a number of studies among larger populations has indicated an elevated risk of postnatal 
transmission through prolonged breastfeeding.243  Mathematical modeling based on these 
studies thus propose a shorter duration of breastfeeding (three to nine months) as a way of 
reducing transmission via breastfeeding.248 Considering the important role played by 
breastfeeding in the early postpartum period, implementing shorter breastfeeding policy and 
early complementary feeding may, however, increase the risk of morbidity and 
mortality.60,249 
Several studies in developing countries have found that mothers in Sub-Saharan 
Africa and other poor settings who cannot afford commercial infant foods face the challenge 
of balancing risks. On one hand, there is the risk of infecting their infants through 
breastfeeding. On the other hand, there is the risk of infant morbidity and mortality as well as 
HIV/AIDS-related stigmatization that is associated with not breastfeeding.250 In some 
communities, the decision to not breastfeed raises suspicions about HIV infection and the 
mother may suffer social, emotional, and physical consequences of stigmatization.  
Most HIV-infected mothers often breastfeed or plan to breastfeed their infants 
regardless of a positive HIV status.251-253 The choice of infant feeding option by HIV-infected 
African mothers is arrived at with considerations of several factors including financial 
constraints, fear of losing confidentiality of HIV status, lack of access to breast milk 
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substitutes, and limitations associated with preparing commercially prepared infant food.253 
The WHO has recently reviewed the recommendation on infant feeding following a technical 
consensus meeting. The available evidence led to the following recommendations for infant 
feeding among women who are HIV positive: “Exclusive breastfeeding is recommended for 
HIV-infected women for the first six months of life unless replacement feeding is acceptable, 
feasible, affordable, sustainable, and safe for them and their infants before that time”.254 The 
current recommendation differs little from earlier ones because it still places responsibility of 
infant feeding choice on the mother/caregiver with support from existing health services. The 
availability and effectiveness of supportive infant feeding counseling is vital to the 
application of this recommendation in low income settings. Achieving this requires more 
trained counselors and communication of new evidence in the prevention of transmission of 
HIV. However the final decision resides with the mother. The counselor is expected to 
provide the mother with current information about the risks associated with the feeding 
method of her choice, as well as provide support for whatever choice the mother makes. 
Mechanisms of MTCT via Breastfeeding 
The mechanisms that account for HIV access into the blood stream are dependent on 
breaches in both infant and maternal immune defenses. Infant oral thrush, a condition of 
candidal infection, has been associated with elevated postnatal transmission.242 Infant oral 
thrush typically affects the epithelium of the mouth and allows HIV in breast milk to enter 
the infant’s circulation. There is also evidence that compromised epithelial integrity of infant 
and fetal gastrointestinal mucosal lining is associated with MTCT. For example, a study by 
Cocchi and Cocchi255 has shown that the conified layer of the infant skin is very thin 
compared to that of the adult. Hence, the infant gut becomes easily vulnerable to increased 
permeability leading to elevated risk of MTCT.256 Dreyfuss and Fawzi257 have demonstrated 
that vitamin A and zinc deficiencies are associated with epithelial impairment in the 
gastrointestinal tract. Thus, deficiency of these nutrients can elevate risk of viral transfer.  
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Maternal factors that may increase the infant’s vulnerability to HIV transmission 
include nipple diseases like eczema, sore nipples, cracked nipples,258  and subclinical 
mastitis.44,259 Willumsen et al.24 have reported the existence of higher HIV RNA viral load in 
the breast milk of women with elevated Na/K at one and 14 weeks postpartum. A recent 
study in Zambia has confirmed the relationship between elevated Na/K and high breast milk 
viral load.135 Studies among HIV-1 infected women have shown that a 10-fold elevation in 
breast milk viral load was associated with a two-fold increase in HIV-1 transmission risk.260  
In an attempt to describe the mechanism for MTCT of HIV, Rousseau et al.261 
determined the concentration of HIV-1 infected breast milk cells per milliliter of milk and 
found this concentration to be higher in colostrum versus mature milk. The authors 
concluded that infected breast milk cells played a greater role in HIV-1 transmission than 
cell-free virus. The essence of this finding is that among HIV infected women, when SCM 
persists, leakage of plasma constituents including infected somatic cells into milk may 
explain the higher risk of transmission to the infant through breastfeeding. 
Anti-retroviral treatment in HIV 
Short course anti-retroviral drugs have proved most effective at reducing the whole 
spectrum of MTCT of HIV.250 ARV therapy reduces transmission of HIV-1 by decreasing its 
levels in both maternal blood and maternal mucosal secretions, resulting in reduced infant 
exposure to the virus.260 The goal of ARV therapy is to reduce viral load as quickly as 
possible in order to: 1) prevent mutations which may lead to resistance to drug therapy, 2) 
reduce viral transport to other areas of the body where current medications are ineffective, 
and 3) allow for immune system recovery and thus slow the progression to AIDS and death.  
The greatest benefit of anti-retroviral therapy in preventing HIV transmission was 
observed in studies involving non-breastfeeding women.262 Studies among breastfeeding 
African mothers have also demonstrated reduced transmission using different regimens. The 
DITRAME trials in La Cote d’Ivoire and Burkina Faso found a 9.54% greater reduction in 
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HIV transmission at six months postpartum among women receiving zidovudine during 
pregnancy, labor, and at one week postpartum compared to women receiving placebo.263 The 
difference in transmission was reduced to 8.5% at 15 months postpartum. Another anti-
retroviral trial in Uganda involving 626 pregnant women randomly assigned one group to 
receive Nevirapine at onset of labor with the infant also receiving Nevirapine within 72 hours 
of delivery.264 The other group of women received Zidovudine at onset of labor and every 
three hours until delivery and the infants received oral Zidovudine twice per day for all of the 
first week postpartum. Almost all the infants (99%) initiated breastfeeding. Between 14 and 
16 weeks of age, 13.5% of the Nevirapine group was HIV-positive compared to 22.1% in the 
Zidovudine group. At 18 months, 15.7% and 25.8% from the Nevirapine and Zidovudine 
respectively were infected. Although anti-retroviral therapy has proven effective at reducing 
transmission of HIV,265 it is still an expensive intervention for economically impoverished 
sub-Saharan African countries.266  
Study area, Ghana 
Ghana is a West African country located between latitude 4.00 N and 11.00 N and 
longitude 3.10 W and 1.10 E in the West African sub-region. Ghana shares international 
borders with La Cote D’ Ivoire to the west, Togo to the East, Burkina Faso to the north and 
has the Gulf of Guinea as its southern border. The total land area of 238,539 square 
kilometers supports a population of 21.4 million people that is growing at a rate of 3%.267 
Total fertility rate is 4.5 children per woman and life expectancy is estimated at 56 years with 
infant mortality of 52.22 deaths/1,000 live births. Malaria accounts for about 22% of all 
deaths in children less than 5 years and 44% of all out-patient clinic attendances. Agriculture 
is the major economic activity of Ghanaians. An estimated 32% of the population lives below 
the poverty line. 
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Breastfeeding practice in Ghana 
The 2003 demographic and health survey (DHS) provides the most current national 
data on infant feeding in Ghana.267 Breastfeeding has always been a common infant feeding 
practice among Ghanaian women. Although 97% of Ghanaian women initiate breastfeeding 
sometime after birth, more than half of these women put their children to the breast well after 
one hour of delivery, contrary to optimal breastfeeding recommendations. For about one 
quarter of women who initiate breastfeeding, the process is initiated after the first 24 hours 
after delivery.  
In the last five years, the DHS shows that the proportion of infants who were 
introduced to the breast within one hour after delivery has increased from 54 to 75%.267 
During the period before the first breastfeed, 19% of infants are given pre-lacteal feeds prior 
to the initiation of breastfeeding. Children who were delivered in a health facility compared 
to those delivered at home were more likely to be breastfed immediately after birth, and less 
likely to be given pre-lacteal feeds. 
The Ghana Health Service (GHS) recommends that all children, unless medically 
contraindicated, be exclusively breastfed during the first six months. However, only 53.4% of 
Ghanaian infant below six months are exclusively breastfed. Nevertheless, this rate 
represents an improvement in EBF recorded in earlier surveys for the same age group (31.1% 
in 1998). Commonly, the exclusive breastfeeding rate starts declining between the second 
and third month postpartum in Ghana. The median duration of any breastfeeding in Ghana is 
23 months. The proportion of children who have been weaned from the breast increases 
rapidly after the first year of life. While less than 5% of infants are not breastfeeding at the 
end of the first year, more than 70% of children are no longer breastfeeding by the end of the 
second year. Some children may breastfeed for as long as the 35th month. Children living in 
rural communities are breastfed longer than their counterparts in urban communities. 
Breastfeeding duration is higher among low income and less educated women. 
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About 63% of Ghanaian infants between the ages of six and nine months are fed solid 
foods (Figure 2.2) in addition to breast milk as recommended by the WHO.267 At this stage, 
however, 5% of infants are still fully breastfed. Infant feeding problems identified include 
mother’s complaints of inadequate breast milk production, earlier-than-recommended 
introduction of complementary feeding, use of feeding bottle, and delayed initiation of 
breastfeeding.  
Complementary feeding in Ghana  
The GHS encourages initiation of complementary feeding at six months postpartum. 
Data from the 2003 Demographic and Health Survey indicate that very few Ghanaian 
breastfeeding infants (less than 10% at six months) receive infant formula. Forty-seven 
percent of breastfeeding infants have been introduced to solid or semi-solid food by the time 
they reach five months old. A majority (53%) of these infants consume foods made from 
grains. Koko, a porridge made from fermented corn or millet, is the most common food given 
to complement breast milk and is given about once a day through the first year and twice or 
more beyond the first year of life. A blend of corn, millet, soybeans, and groundnuts is 
recommended as a nutrient-rich substitute for koko preparation rather than the traditional 
corn meal. However, the consumption of this blend was not described in this survey.  
In addition to its six months EBF policy, the GHS promotes the addition of safe and 
affordable foods to complement the nourishment provided by breast milk beyond the 6th 
month. This recommendation is encouraged until the child is two years old. Thereafter, the 
infant may be weaned completely from breast milk. These recommendations are first 
presented to most Ghanaian mothers when they start attending child welfare clinics (CWC) at 
the sixth week postpartum. For a few mothers who have access to BFHI institutions, there 
may be an opportunity to learn these recommendations earlier than their first CWC visit. The 
BFHI was first initiated in Ghanaian health facilities in 1993. Most major hospitals and 
clinics have been trained and certified as baby friendly institutions. However, a majority of 
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women lack both physical and economic access to these hospitals. Ghana has in place 
legislation under the Food and Drugs Law to control the marketing of breast milk substitutes 
by baby food manufacturers in support of the global code on marketing of breast milk 
substitutes. 
Trends of HIV infection in Ghana 
HIV infection was first reported in Ghana in 1986 and the infection rate has since 
been increasing steadily.268 HIV-1 is the predominant infecting agent (94.8% of cases) 
among Ghanaians. Currently, 2.3% of adult Ghanaians are infected with HIV, representing a 
modest decrease from 3.1% at the end of 2004.269 There is, however, regional variation in 
prevalence that ranges from 1.2% in the northern regions to 4.7% in the Eastern region. 
Unusually high rates (19%) have been noted among prison inmates270 and prison officers 
(8.5%). Current estimates of 350,000 infected include 180,000 adult women (15-49 yr) and 
24,000 children less than 15 years of age. While most HIV infection occurs among females, 
male infection has been rising steadily. At the end of 2005, about 14,449 AIDS cases were 
recorded in Ghana, contributing to a cumulative 104,995 AIDS cases since the epidemic was 
detected. The main driving force of the infection in Ghana is unprotected heterosexual 
intercourse. 
HIV control strategies in Ghana 
Prevention is the core strategy of HIV control in Ghana. The Ministry of Health 
through the national AIDS control program, and with support from non-governmental 
agencies, is promoting a three stage control strategy involving abstinence from casual sex, 
faithfulness to sexual partners, and the use of condoms (ABC program). Starting in 2001, the 
ministry of health provided facilities at major public hospitals that provide services for 
prevention of MTCT. The number of such facilities continues to expand as the facilities and 
infrastructure become acceptable for use in programs to prevent MTCT throughout the 
country.  
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Pregnant mothers attending antenatal clinic at institutions that provide MTCT 
prevention services are offered voluntary counseling and testing for HIV. In a limited number 
of institutions where treatment is available, anti-retroviral therapy is provided to pregnant 
women who test positive for HIV. Beyond 28 weeks of pregnancy, HIV-positive women 
with CD4+ > 350 cells/m3 receive a double treatment of Zidovudine through labor till the 
seventh day postpartum. Pregnant women with CD4+ < 350 cells/m3 receive a triple 
treatment regimen. Additionally, both the mother and infant are given a single dose of 
Nevirapine prophylaxis intrapartum. The infant is subsequently given Zidovudine during the 
first seven days postpartum (personal communication, Dr Brakohiapa, L). 
In addition to ART, policies have been put in place to help expectant mothers make 
informed choice about infant feeding that will protect the infant from possible infection 
through breastfeeding. There are, however, problems with operationalization of these policies 
since the cost of infant formula is beyond the purchasing power of most mothers. Also, the 
fear of stigma attached to not breastfeeding and related suspicion of HIV infection makes it 
difficult for mothers to exercise their choice of infant feeding, if it is an alternative to 
breastfeeding. HIV-infected mothers receive counseling on risks and benefits of 
breastfeeding and on other infant feeding options. The mother is then expected to make a 
decision on a feeding option that is feasible, safe, and sustainable. The mother then receives 
support to practice her chosen feeding option.  
Manya Krobo 
The studies reported in this dissertation were conducted in both rural and peri-urban 
communities in the Manya Krobo district of Ghana. The Manya Krobo district is one of 17 
administrative districts in the Eastern region of Ghana (Figure 2.3). Manya Krobo district has 
a population of 165,409 living mostly in rural communities. Most communities in the district 
have access to pipe-borne water obtained from community stand pipes. A majority of 
residents in the district are involved in farming, fishing, trading and artisanal pottery. Most 
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households in larger towns have access to pipe borne water. Otherwise, water is obtained 
from hand dug wells where available. Breastfeeding is the norm for most infants from birth 
and continues beyond twelve months. However, introduction of liquids and semisolids starts 
early. Breastfeeding is commonly complemented with koko, a fermented maize porridge by 
three months postpartum.267  
The district is served by three hospitals and a number of health centers. Health 
services include prenatal counseling and infant growth monitoring, infant feeding counseling, 
immunizations, and micronutrient supplementation at child welfare clinics. The district 
administration runs a community-based health insurance scheme as part of the National 
health insurance scheme. In 2005, HIV prevalence in Manya Krobo declined from 7.4 to 
5.0%. Voluntary counseling and testing services and prevention of MTCT for HIV are 
provided at the three hospitals where mothers receive standard ART as indicated above. 
Counseling services are also provided to help HIV positive mothers make an informed infant 
feeding decision as recommended by the World Health Organization.271 Earlier studies of 
HIV positive mothers indicate that most choose to breastfeed their babies after counseling on 
the risks of transmission during breastfeeding.272 The study also found that perceived stigma 
was associated with the decision to breastfeed. Mothers were concerned that refusal to 
breastfeed will cause family and neighbors to suspect their HIV status. There are also 
indications that mothers unduly postpone their need to seek medical care. This delay may be 
due to the common use of traditional remedies.  
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Figure 2.1. Proposed pathways by which Subclinical mastitis (SCM) affects infant 
growth 
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Figure 2.2. Infant feeding behavior of Ghanainan infants (modified from GSS/ORC 
Macro Int, 2004) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
50 
 
 
 
 
Figure 2.3. Map of Ghana showing location of Manya Krobo 
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Chapter 3. General Methods 
Study design 
The three studies reported in this dissertation were conducted in the same district in 
Ghana. Each study involved the recruitment of a different set of mothers. There had 
previously been no study on SCM or any other breast health problems among lactating 
women in Ghana.  
The first study investigated the prevalence of SCM among a community of Ghanaian 
lactating women. We hypothesized that SCM will be detected in at least one quarter of 
lactating women at three or four months postpartum. Knowledge of SCM prevalence was 
necessary for two reasons: 1) to determine whether SCM was of public health importance in 
the Ghanaian setting and thus worth pursuing as a research project, and 2) to decide what 
sample size would be appropriate for the subsequent studies included in the project. 
 A longitudinal study was subsequently carried out to determine the association 
between SCM and infant growth and feeding practices beyond the third month postpartum. A 
cross-sectional study of infant breast milk intake was carried out with a separate group of 
mother-infant pairs to investigate the effect of SCM on infant breast milk intake. 
Ethical approval and informed consent 
Ethical approval was obtained from the Institutional Review Boards of Iowa State 
University (ISU) and the Noguchi Memorial Institute for Medical Research (NMIMR) at the 
University of Ghana. Additionally, a formal letter of approval and support was obtained from 
the Manya Krobo District health administration. Written informed consent was obtained from 
all participants in each study. 
Study area and participants  
All three studies were carried out in the Manya Krobo district of the Eastern region of 
Ghana. The district is situated at Longitude 0° and Latitudes 6°15′ north of the equator and is 
about 45 minutes driving from Accra, the capital city. Manya Krobo is mostly rural with a 
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population of 165,409 persons.273 The hilly nature in parts of the district creates two main 
ecological zones for the district. Lower Manya is a low lying zone consisting of both peri-
urban and rural communities with some access to social and utility services. Upper Manya 
consists of largely rural farming communities located in the hilly zone of the district (about 
500 to 660 m above sea level). The upper Manya communities have less access to social and 
utility services.  
The ecology of the district is suitable for vegetable and fruit farming which constitute 
the main occupation of the district. On the north-eastern boundary of the district is the Volta 
lake from which the men harvest freshwater fish to be sold by women. In peri-urban 
communities, however, women are mostly artisans or traders who sell food and household 
commodities.  
Most communities in the district have access to pipe-borne water, primary education, 
and health services that include prenatal counseling, infant growth monitoring, infant feeding 
counseling, immunizations, and micronutrient supplementation, all of which are accessible 
from, often, mobile child welfare clinics (CWC). The district and indeed the entire Eastern 
region have a high HIV prevalence rate. The 2004 sentinel surveillance revealed that HIV 
prevalence surveyed at the Atua Hospital in the district was 7.4%, and at the time, that rate 
was higher than anywhere else in the country.269 The rate has since declined to 5.0%  in 
2005.274 Due to the relatively high prevalence of HIV, the district was among the first to 
benefit from services and support for voluntary counseling and testing of HIV in two of its 
hospitals. In addition to these services, infant feeding counseling and support is currently 
provided to pregnant mothers to reduce the risk of mother-to-child transmission of HIV. 
However, these services are centralized and are mostly accessible to women living in the 
lower Manya area. 
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Rapid survey 
Study design 
The rapid survey was designed to obtain a quick appraisal of the occurrence of breast 
health problems among lactating women at three and four months postpartum in a Ghanaian 
community. 
Sample size determination 
A sample size of 110 mothers was estimated for the rapid survey. This sample size 
was determined based on the prevalence of SCM reported in previous studies24,37 and was 
expected to give the study a power of 80% to detect at least a 25% prevalence of SCM in the 
study population. The prevalence of SCM among lactating women in Manya Krobo at 3 
months postpartum was assumed to be similar to that of lactating women in other African 
countries.24,37 The confidence limit was set at 95%. 
Study participants 
One hundred and seventeen lactating women were recruited from 10 CWC in this 
study. Women who have had singleton births and were attending CWC during the 
recruitment period (November 2005 to January 2006) were invited to participate if they were 
three to four months postpartum, at least 18 years old, and resident in the Manya Krobo 
district.  
Data collected from participants 
Study mothers completed a brief survey on recent health history including self-
reported overall health perception including questions like, “How would you describe your 
health today”? and “Have you had any other health problems in the last week”? Breast health 
questions included: “Have you had breast pain/swelling since you had this child and if the 
answer is yes, when did it occur? Data on maternal age and number of live births were also 
collected. Maternal mid-upper arm circumference (MUAC) was measured to the nearest 0.1 
cm on the left arm using a non-stretchable tape measure (Chasmors Ltd, London). No 
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information on infant health, feeding, and growth were collected. A spot breast milk sample 
of at least 10 mL was obtained from each breast of each mother by manual expression.  
 Breast milk collection and storage 
Before expressing breast milk, the women washed both hands thoroughly with 
disinfectant liquid hand soap and running water, rinsed with deionised water and dried their 
hands with clean paper towels. The first drops of expressed breast milk were discarded after 
which the nipple and surrounding areola was cleaned with cotton gauze soaked with 70% 
ethyl alcohol. Breast milk expressed thereafter was collected in 60 mL plastic vials with 
snap-on caps. Upon completion of expression from one side, hand rinsing was repeated with 
deionised water and breast surface cleaning with ethyl alcohol was carried out before 
continuing to express milk from the other breast. All breast milk samples collected were 
immediately stowed in a cold chest for transportation to the field laboratory where it was 
stored at -20 0C. Samples were subsequently transported to Accra, for storage at -32 0C until 
analyses. 
Laboratory methods 
Sodium and potassium content analyses were performed using standard methods that 
employ ion-selective electrodes.141 Briefly, all analyses were performed on whole milk 
without any sample pre-treatment. Samples were thawed to room temperature (25 0C). 
Thawed milk was then homogenized using a vortex mixer to allow the aqueous and lipid 
compartments to mix uniformly and 0.1 mL of sample was aspirated for analyses of sodium 
and potassium using ATAC 8000 ion-selective electrode analyzer (Clinical Data Inc, 
Smithfield, USA). In addition to the internal saline standards used by the ATAC 8000, 
analytical quality was monitored by simultaneous analyses of milk and a saline standard with 
known electrolyte concentration. 
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Statistical analyses 
All data were analyzed using SPSS 15.0 (SPSS Inc, Chicago). Descriptive statistics 
including arithmetic mean, median, and standard deviations were computed for maternal age 
and MUAC data. Our MUAC data were compared with a MUAC reference threshold of 18.5 
cm for screening moderate undernutrition.200 Categorical maternal health data were 
summarized into frequencies. Results of breast milk analyses were expressed as Na/K ratio 
for each sample. Geometric mean was computed to describe the asymmetric distribution of 
Na/K data. SCM status groups were defined based on Na/K ratio in either one (unilateral) or 
both breasts (bilateral). Analysis of variance was used to test group differences in log 
transformed Na/K data. Differences were considered significant in this study at p < 0.05. The 
prevalence of SCM was computed as the percentage of women with Na/K > 1.0.24,37 
Longitudinal study 
Study design 
The longitudinal study was conducted between February and October, 2006. The 
mother-infant pairs recruited into this study were observed during regularly scheduled home 
visits carried out every two weeks over a total duration of three consecutive months between 
the third and sixth month postpartum. With the exception of those who were lost to follow-
up, each mother-infant pair was observed seven times.  
Sample size determination 
Sample size estimation for this study was based on SCM prevalence reported in 
previous studies24,37 as well as observed infant growth characteristics in Ghana and 
elsewhere.266,275 A total of 110 women and their singleton infants were estimated to be 
recruited into the study. This number of mother-infant pairs was required to test the 
hypotheses relating SCM to reduced infant growth and infant feeding as indicated in Table 
3.1. All estimations were based on a power of 80%, a confidence limit of 95% and expected 
attrition of 20%. 
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Study participants  
Most mothers included in the study were from peri-urban communities in the Manya 
Krobo district. One hundred and sixty three lactating women were invited from nine CWC to 
participate in the longitudinal study. However, only 115 women were available at baseline 
while 108 women remained in the study until the seventh observation. Inclusion criteria for 
women in the study were: residence in the Manya Krobo district, less than 3 months 
postpartum, at least 18 years, and willingness to continue participation with their infants 
through the entire duration of the study. Women with twin births were excluded from 
participating in the study. 
Data collection procedures and tools 
 All recruitments were done prior to the infant attaining three months old; 
observations were initiated on the day the infant turned three months old and subsequent 
home visits were scheduled two weeks ahead of each previous home visit. In some cases, the 
mothers were not available for observation on the scheduled date of home visit. When that 
situation occurred, arrangements were made for observation to be carried out on a day as 
close to the scheduled visit day as possible. More often than not, such visits were carried out 
one day before or after the planned date of observation.  
At recruitment, a brief demographic survey was completed by trained field workers. 
Field workers also recorded the home addresses of mothers using popular land marks, and 
community names. Where possible, maps were drawn by field assistants, with the assistance 
of the mother to enable easy access to mother’s home for observations. At recruitment, a 
date, time and place for the first home visit was arranged with each mother. Subsequent 
home visit appointments were made after each home visit.  
During the home visits, field workers collected maternal and infant health histories 
covering the seven days prior to the day of the home visit. This information was recorded in a 
questionnaire designed specifically for that purpose (appendix 3b). The questionnaire 
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collected information on the occurrence of common disease symptoms for both mother and 
infant as well as the frequency of occurrence of these conditions in the last seven days. 
A food frequency questionnaire was used to record all breast milk, and other liquid 
and solid foods taken by the infant during the last seven days. The frequency of water and 
multivitamin intake during the same period was also recorded. The food frequency tool used 
was an abridged version of one that has been tested and is currently being used by other on-
going studies in the district.  
Maternal weight and standing height were measured at baseline by trained field 
workers. Maternal weight measurements were taken a second time among some but not all 
mothers on the seventh visit. Infant weight, head circumference, mid-upper arm 
circumference and length were measured and recorded at baseline. All infant measurements 
were carried out during each home visit.  
All anthropometric measurements were carried out using standard procedures. Infant 
weight was measured by tarring using the Tanita BWB800S digital floor scale (Tanita 
Corporation; Tokyo, Japan).  Most infants were measured without clothing; in some cases, 
infants were measured with clothing and their net weight was determined as the difference 
between the clothing and the weight with clothing. Maternal weight was also measured using 
the Tanita BWB800S digital floor scale. Head circumference was measured to the nearest 0.1 
cm using a non-stretchable tape measure (Chasmors Ltd.; London, United Kingdom). The 
same tape was also used to measure infant mid-upper arm circumference. Infant recumbent 
length and maternal height were measured to the nearest 0.1 cm using the Shorr 
infant/child/adult/height/length measuring board (Shorr Productions; Maryland, USA).  
About 5 mL of breast milk expressed manually from each breast were obtained from 
each mother at each home visit. Breast milk samples were stored in clean plastic vials with 
screw top caps for transportation to the field laboratory. The same breast milk collection 
protocol described for the rapid survey was observed in the collection of breast milk samples 
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for the longitudinal study. All breast milk samples were transported on ice to the Noguchi 
Memorial Institute for Medical Research laboratories in Accra to be stored at -32 0C until 
analysis.  
Laboratory analyses 
Sodium and potassium content analyses were performed using standard methods that 
employ ion selective electrode analyzer.141 Briefly, all analyses were performed on whole 
milk without any sample pre-treatment. Samples were thawed to room temperature (25 0C). 
Thawed milk was then mixed using a vortex mixer to allow the aqueous and lipid 
compartments to mix uniformly and 0.1 mL of sample was aspirated for analysis of sodium 
and potassium using Medica Easylyte ion-selective electrode analyzer (Medica Corporation; 
Bedford, USA). In addition to the internal saline standards used by the Medica Easylyte 
analyzer, analytical quality was monitored by simultaneous analyses of milk with a saline 
standard with known electrolyte concentration.  
Statistical analyses 
All data were analyzed using SPSS 15.0 (SPSS Inc, Chicago). Descriptive statistics 
including arithmetic mean, median, and standard deviations were computed for continuous 
maternal and infant data. Categorical maternal and infant data were summarized into 
frequencies. Breast milk sodium and potassium data were expressed as Na/K. The prevalence 
of SCM was computed as the percentage of women with Na/K > 1.0. Multiple linear 
regression analysis was performed to determine the predictors of infant growth. Differences 
between groups were considered significant study at p < 0.05.  
Cross-sectional study 
Study design 
This cross-sectional study was designed to compare the breast milk intake of infants 
whose mothers had SCM with those whose mothers did not.   
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Study participants 
Data for the cross-sectional study were collected between July 2006 and February 
2007. A total of 72 mother-infant pairs were recruited from 7 CWC in the Manya Krobo 
district to participate in the study. Inclusion criteria for women recruited for the cross-
sectional study were: mother aged at least 18 years, breastfeeding infant at recruitment, has 
singleton birth of infant aged between 3 and 6 months and willing to participate in a 12- hour 
breast milk intake observation.  
Data collection procedures and tools 
At recruitment, a field worker explained the protocol of the study to the mother. Upon 
acceptance of study procedures and completion of the informed consent document, women 
were then recruited to participate in the study. Mothers were asked to provide detailed 
directions to their homes. Where necessary, maps were sketched by field workers to enable 
ease of access to mother’s address.  
At a scheduled date during the 3rd and 6th months postpartum, each mother was 
visited at her home to collect at least 5 mL of breast milk from each breast using plastic vials 
rinsed with de-ionized water. All breast milk samples were collected by manual expression 
using the protocol described earlier in the description of the rapid survey. A 12-hour home 
visit was then scheduled for the next day.  
Breast milk analyses protocol 
About 2 mL of the breast milk sample collected was tested for subclinical mastitis 
immediately after milk collection using the California mastitis test (CMT). The CMT 
procedure involved mixing 2 mL of breast milk with an equal amount of the CMT reagent in 
a test cup and swirling the cup in counter clockwise manner. Thickening or gelatinization of 
the mixture after about 10 seconds was indication for SCM. The severity of SCM was related 
to the degree of thickening observed.147 
60 
 
 
The rest of the breast milk was kept on ice in a sealed container and transported to 
storage in a freezer at -32 0C until it was analyzed for sodium and potassium content. Sodium 
and potassium analyses were carried out with Easylyte (Medica Corporation, Bedford, USA), 
an electrolyte analyzer that utilizes ion-selective electrode technology. Electrolyte analyses 
involved thawing of milk to room temperature and then drawing 0.01 mL of milk into the 
analyzer for analyses.141  
Breast milk intake  
During the 12-hour home visit, breast milk intake by the infant was estimated for 
each breastfeed using the test weighing procedure.189,276 Briefly, the process involved 
recording the weight of the infant just before and then immediately after the infant is 
breastfed without a change of clothing or diapers in between the process. 
Infant health and dietary intake 
During the home visits, field workers collected maternal and infant health histories 
covering the seven days prior to the day of the home visit. This information was recorded in a 
questionnaire designed specifically for that purpose (appendix 4c). The questionnaire 
collected information on the occurrence of common disease symptoms for both mother and 
infant as well as the frequency of occurrence of these conditions in the last seven days. 
A food frequency questionnaire was used to record all breast milk, and other liquid 
and solid foods taken by the infant during the last seven days. The frequency of water and 
multivitamin intake during the same period was also recorded. The food frequency tool used 
was an abridged version of one that has been tested and is in current use by other on-going 
studies in the district (appendix 4b). 
Anthropometry 
All anthropometric measurements were carried out using standard procedures. Infant 
weight was measured using the Tanita BWB800S digital floor scale (Tanita Corporation; 
Tokyo, Japan). All infants were measured with clothing. Maternal weight was measured also 
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using the Tanita BWB800S digital floor scale (Tanita Corporation; Tokyo, Japan). Head 
circumference was measured to the nearest 0.1 cm using a non-stretchable tape measure 
(Chasmors Ltd.; London). The same tape was used to measure infant mid-upper arm 
circumference. Infant recumbent length and maternal standing height were measured to the 
nearest 0.1 cm using the Shorr infant/child/adult/height/length measuring board (Shorr 
Productions; Maryland, USA).  
Statistical analyses 
All data were analyzed using SPSS 15.0 (SPSS Inc; Chicago). Descriptive statistics 
including arithmetic mean, median, and standard deviations were computed for maternal age, 
parity, and infant and maternal anthropometry data. Categorical maternal health data were 
summarized using frequencies. SCM was diagnosed using CMT > 1 and Na/K > 1.0. 
Differences in breast milk intake across groups were described using 95% confidence 
intervals. Group differences were considered significant in this study at p < 0.05.  
 
Table 3.1. Estimates used in computing sample sizes 
Outcome D* p* SD Sample size 
Incidence of high Na/K‡a  15 % 19 %  107 
3-6 months non-exclusive breastfeeding rate‡b  25 % 60 %  60 
Growth†c 70 g/month  0.1 44 
a Gomo et. al.37   b GSS,267  c Baumgartner et. al.275 
1 Sample size equation: 
 ‡n = (Zα/2 +Zβ)2 p*(1-p*) (r+1) 
                     (d* )2 r  
                                                        
    †n = (Zα/2 +Zβ)2 SD2 (r+1) 
                     (d* )2 r  
Zα/2=standard normal distribution of d* at α=5 %                     
Zβ=standard normal distribution of d* for 80 % power.           
SD= observed standard deviation associated with d*               
P*= estimated incidence of SCM        
D*= expected difference in proportions/means                                       
r = ratio of women with SCM to those without SCM 
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Abstract 
Subclinical mastitis (SCM) is an asymptomatic inflammation of mammary tissue and 
has been associated with lactation failure, sub-optimal growth in early infancy, and increased 
risk of mother-to-child transmission of HIV via breast milk. We carried out a rapid survey to 
determine the prevalence of SCM among lactating Ghanaian women between 3 and 4 months 
postpartum. Bilateral breast milk samples were obtained from 117 lactating women in Manya 
Krobo, Ghana and analyzed for sodium (Na) and potassium (K). Additionally, we measured 
maternal mid-upper arm circumference and recorded recent maternal health history. An 
elevated sodium-potassium ratio (Na/K) above 1.0 was considered indicative of SCM. 
Overall, SCM prevalence was 45.3% of which 29.9% was unilateral. Na/K was not 
associated with maternal health or nutritional status. The rate of SCM in this community is 
high; there is the need for lactation support to reduce SCM, thereby reducing the risk of 
adverse infant outcomes. 
 
Keywords: breastfeeding, infant growth, subclinical mastitis, sodium:potassium ratio, Ghana 
Introduction 
Suboptimal breast health may compromise maternal ability to breastfeed and the 
well-being of a breastfeeding infant. Subclinical mastitis (SCM) is an asymptomatic 
inflammatory condition of the lactating breast.1 The condition is associated with a number of 
adverse outcomes including lactation failure,2 infant growth faltering during the early 
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postpartum period,2,3 and increased risk of mother-to-child transmission of the Human 
Immunodeficiency virus (HIV).4  
SCM is thought to be caused primarily by milk stasis,5 which results from inadequate 
milk removal from the breasts. Milk stasis can increase the risk of bacterial infection of 
stagnated milk in the breast, occasionally leading to infectious mastitis.6 During an episode 
of SCM, the tight epithelial junctions separating milk and plasma become compromised, 
leading to the leakage of plasma components, including sodium and chloride ions into milk.7 
An elevated sodium-potassium ratio (Na/K) above 1.0 is considered indicative of SCM.4,5 
The present study was carried out to determine the prevalence of SCM among 
lactating Ghanaian women during the three to four month postpartum period. This study was 
conducted in Ghana as part of a larger study to determine the mechanism(s) linking SCM 
with infant growth faltering. 
Methods 
Study area and participants  
The study was conducted in the Manya Krobo district in the Eastern region of Ghana 
between November 2005 and February 2006. Most communities in the district have access to 
potable water and health services that include prenatal clinics and infant growth monitoring, 
immunizations, and vitamin A supplementation that are accessible at child welfare clinics. 
Manya Krobo has a population of 165,409 living mostly in rural communities.8 The majority 
of the women recruited into the current study, however, were residing in peri-urban 
communities where CWC were most accessible. In 2004, HIV prevalence in Manya Krobo 
was 7.4%.9 During the study period, there were three health institutions in the district that 
provided HIV voluntary counseling and testing services and infant feeding counseling to 
reduce the risk of mother-to-child transmission of HIV. 
We hypothesized that SCM would be detected in at least one quarter of lactating 
women at 3 to 4 months postpartum based on the findings from a study in South Africa in 
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which the authors reported that 25% of lactating women had Na/K > 1.0 at 3 months.1,4 A 
sample size of 110 women was thus estimated, based on a statistical power of 80% to 
demonstrate the suggested prevalence in this population of lactating Ghanaian women.1,4 
Confidence limits were set at 95%. One hundred and seventeen lactating women were 
recruited from 10 CWC for this study. Women were invited to participate if they were 3 to 4 
months postpartum, at least 18 years old, and resided in the Manya Krobo district. Written 
informed consent was obtained from all participants. 
Approval was obtained from the Institutional Review Boards of Iowa State University 
(ISU) and the Noguchi Memorial Institute for Medical Research (NMIMR) at the University 
of Ghana. Additionally, a formal letter of approval and support was obtained from the Manya 
Krobo district health administration.  
Data collected from participants 
Study participants completed a brief survey on the following questions on self-
reported health indicators, to determine their associations with the development of SCM: 
overall health evaluation (‘How would you describe your health today?’); breast health 
(‘Have you had breast pain since you had this child?’ and ‘If yes, when did it occur?’); and 
recent disease symptoms (‘Have you had any other health problems in the last week?’). 
Maternal age and number of live births were collected also. Mid-upper arm circumference 
(MUAC), a crude indicator of nutritional status, was measured on each participant to the 
nearest 0.1 cm on the left arm using a non-stretchable tape measure (Chasmors Ltd.; London, 
United Kingdom).   
Milk collection protocol and storage 
A spot milk sample of at least 10 mL was obtained by manual expression from each 
breast of each participant. Before expressing breast milk, the women washed both hands 
thoroughly with disinfectant liquid hand soap and running water, rinsed with deionised water 
and dried their hands with clean paper towels. The first drops of expressed milk were 
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discarded after which the nipple and surrounding areola were cleaned with cotton gauze 
soaked with 70% ethyl alcohol. Milk expressed thereafter was collected in 60 mL plastic 
vials with snap-on caps. Upon completion of expression from one side, hand rinsing was 
repeated with deionised water and breast surface cleaning with ethyl alcohol before milk was 
expressed from the other breast. This hand washing protocol was observed by the women as 
well as the field staff who assisted the women to express the milk. The reason for the hand 
washing protocol was to reduce contamination of the milk by perspiration on the hands and 
breast of the woman. The alcohol swab was used to reduce microbial contamination of the 
sample as a portion of milk was cultured for bacterial infection. Data for bacterial culture is 
not reported in this article. All milk samples collected were immediately stored in a cold 
chest for transport to the field laboratory and stored at -20 0C. Samples were subsequently 
transported to Accra, for storage at -32 0C until analysis. 
Laboratory methods 
Milk sodium and potassium content analyses of breast milk samples were performed 
using standard methods that employ ion selective electrode analyzer.10 Briefly, all analyses 
were performed on whole milk without any sample pre-treatment. Samples were thawed to 
room temperature (25 0C). Thawed milk was then homogenized using a vortex mixer to 
allow the aqueous and lipid compartments to mix uniformly and 0.1 mL of sample was 
aspirated for analyses of sodium and potassium using ATAC 8000 ion-selective electrode 
analyzer (Clinical Data Inc; Smithfield, USA). In addition to the internal saline standards 
used by the ATAC 8000, analytical quality was monitored by simultaneous analyses of milk 
and a saline standard with known electrolyte concentration. All milk analyses were carried 
out once. Duplicates were only performed when unusually high sodium concentrations (> 10 
mmol/L) were obtained. 
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Data analyses 
All data were analyzed using SPSS 15.0 (SPSS Inc; Chicago). Descriptive statistics 
including arithmetic mean, median, and standard deviations were computed for maternal age 
and MUAC data. MUAC data were compared with a MUAC reference threshold of 18.5 cm 
for screening moderate undernutrition.11 Categorical maternal health data were summarized 
into frequencies. Results of the milk analyses were expressed as Na/K ratio for each sample. 
Geometric mean was computed to describe the asymmetric distribution of Na/K data. SCM 
status groups were defined based on Na/K ratio in either one (unilateral) or both (bilateral) 
breasts. Analysis of variance was used to test group differences in natural log transformed 
Na/K data. Differences were considered significant in this study at p<0.05. The prevalence of 
SCM was computed as the percentage of women with Na/K> 1.0.4,5 
Results 
Population Characteristics 
Over a period of three months, we screened 1296 women who attended the selected 
CWC of whom 154 women were 3-4 months postpartum. Of these, 6 women refused to 
participate while 31 were excluded because the mother was either not available at the clinic 
(n=21), under 18 years of age (n=3), had a twin birth (n=1), or was previously enrolled into 
the study at an earlier visit (n=6). In total, 117 women met the inclusion criteria and were 
enrolled in the study (Figure 4.1). 
About 42% (n=49) of women in our study were between 18 and 25 years of age while 
23% (n=27) were 30 years or older (Table 4.1). The median MUAC of the women was 26.6 
cm. More than 81% (n=95) of the women had 3 or fewer live birth experiences; 30% were 
primiparous (n=35). Although most of the women (92%; n=108) reported being in good 
health, a few complained of general body pains (5.1%), waist pain (3.4%), fever (3.4%) and 
headaches (2.6%) within the last seven days. Sixteen women reported postpartum breast 
health problems including engorgement (11.9%) and breast pain (6.7%) with 5.1% reporting 
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both engorgement and pain. One woman each reported sore nipples and a boil on the breast. 
Only four of the reported symptoms occurred within the two weeks prior to enrollment into 
the study.  
A total of 229 breast milk samples were collected constituting 112 bilateral samples 
and 5 unilateral samples (participants were unable or unwilling to provide milk from the 
second breast). The median duration of milk expression was 5 to 10 minutes for each breast.  
Na/K and SCM prevalence 
The sodium and potassium levels in milk from right and left breasts are presented in 
Table 4.2. A wide range in milk sodium and potassium levels from both right and left breasts 
was observed. We found no significant differences between left and right breast milk samples 
for sodium (p=0.80) or potassium (p=0.89).  
The geometric mean breast milk Na/K was 0.84; there was no difference in Na/K 
between right and left breasts. The Na/K in breast milk from women with unilateral SCM 
was significantly greater than Na/K in women without elevated Na/K in both breasts 
(p<0.01). There was no significant difference between Na/K in milk from women with 
bilateral and those with unilateral SCM. Na/K was not associated with parity, reported 
maternal health perception, and reported breast health problems at anytime after delivery. 
However, maternal MUAC below 29 cm (p<0.003) and age below 34 years (p<0.017) were 
both associated with higher Na/K. 
Using a Na/K ratio of 1.0 as a threshold, 45.3% of participants had elevated breast 
milk Na/K indicative of SCM. Unilaterally elevated Na/K was observed in 29.9% of the 
study population while 15.4% had bilaterally elevated Na/K.  There was a significant 
between-breast difference in Na/K (p<0.01) among women with unilaterally elevated Na/K 
(Figure 4.2). 
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Discussion 
This study documented very high rates of elevated Na/K among lactating women 
reporting excellent health and no indication of malnutrition. Previously published reports of 
the prevalence of Na/K > 1.0 have ranged between 9 and 25% at three months postpartum.1,4 
We focused on women who were between three and four months postpartum for two reasons: 
firstly, to provide data beyond the third month postpartum period since most of the available 
data on SCM reports data up to three months postpartum, and secondly, the one month 
interval between 3 and 4 months was to reduce a dilution effect of the prevalence estimate 
since SCM prevalence typically reduces over time postpartum.1,17  Our results therefore 
confirm previously reported sustained high SCM prevalence of 23%4 and 25%1 at 14 weeks 
postpartum, suggesting that SCM may occur beyond the third month postpartum.  
It has been reported that healthy women at one month postpartum had breast milk 
Na/K ≤ 0.6.10 Some studies have reported moderate SCM, diagnosed as Na/K > 0.6 but ≤ 
1.0.1,3,12  Moderate SCM may therefore have a lower predictive power for outcomes 
associated with SCM, compared to Na/K > 1.0. In their study of HIV infected women, 
Willumsen et al.4 reported significant elevation of breast milk viral load in women with 
breast milk Na/K > 1.0 compared to those with 0.6 < Na/K ≤ 1.0. Both lactogenesis and 
weaning are associated with increased mammary permeability and leakage of plasma 
electrolytes into milk spaces, thereby increasing breast milk sodium concentration.5,7 
Average breast milk sodium and potassium concentration ranges between 5 and 6 
mmol/L and 13 and 14 mmol/L, respectively, beyond the lactogenesis and weaning periods.10 
In our study, a wide range in both sodium and potassium concentration were observed. The 
observed wide range in concentration was not surprising because among women without 
SCM, breast milk electrolyte concentration is tightly regulated. However, leakage of the 
alveolar epithelium leads to a spike in the breast milk concentration, far above that which is 
observed in the absence of mammary inflammation.  
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It is not known whether SCM at this later stage in lactation (i.e., 3-4 months 
postpartum) continues to affect weight gain and other infant outcomes. If it does, there will 
be need for interventions to reduce SCM rates beyond early lactation period. A trial in 
Bangladesh has indicated a protective effect of lactation counseling before or after birth on 
the rate of SCM during the early postpartum period.12 The effect of a similar intervention on 
the rate of SCM occurring at a later period in lactation remains untested.   
Detailed information on infant feeding was not collected in this rapid survey. Results 
from other studies,4 however, lead us to assume that early introduction of complementary 
feeding may partly explain the high SCM prevalence observed in this community. Typically, 
complementary feeding starts at three months or earlier in Ghana.13 Early introduction of 
complementary feeds has been associated with infrequent breastfeeding and reduced breast 
emptying, both of which can lead to milk stasis and subsequent elevation of breast milk 
sodium.14  
MUAC ≤ 18.5 is considered an indicator of severe malnourishment among adults.11 
Women in our study who had MUAC below 29 cm had higher Na/K. Filteau et al.3 have 
demonstrated that maternal supplementation with vitamin E reduced breast milk Na/K. Low 
maternal MUAC may suggest underlying poor nutritional status although the link between 
low MUAC and poor micronutrient status at this stage may only be implied since there is no 
data clearly establishing a relationship. The lower Na/K among women aged 34 years and 
above may be a function of higher parity and lactation experience. Earlier studies have 
reported that primiparous15 and women between 21 and 35 years16 had a higher risk of 
mastitis.     
While SCM has been found to be high among populations with high HIV 
prevalence,4,17 the effect of HIV infection on SCM in this community remains unknown 
because we did not test for HIV. At the current HIV prevalence of 5%, its effect on SCM 
prevalence among our study participants is likely to be small. We, however, recommend that 
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future studies assess HIV status to allow determination of the contribution of HIV infection 
to the incidence of SCM.   
Conclusion 
The high prevalence of SCM observed in this community suggests the need for 
further investigation to determine the factors that promote elevated Na/K among these 
women and immediate interventions to decrease the prevalence of SCM and the risk of 
adverse outcomes to the infants. Interventions should be targeted at younger and 
malnourished mothers who are at a higher risk of elevated Na/K. 
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Table 4.1. Characteristics of lactating Ghanaian women, 3-4 mo postpartum (N=117) 
Maternal characteristics Mean SD Median Range 
Age, y 27.0 5.8 27.0 18.0 – 46.0 
Live births, # 2.5 1.4 2.0 1.0 – 9.0 
Mid-upper arm circumference, cm 27.3 3.3 26.6 19.3 – 36.5 
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Table 4.2. Sodium and potassium levels in milk of lactating Ghanaian women, 3-4 mo 
postpartum 
Milk characteristics1  Geometric Mean SD Range N 
Right breast      116 
Sodium, mmol/L   11.23 16.78 4.56 - 115.90  
Potassium, mmol/L 13.53 12.57 4.56 - 91.50  
Sodium/Potassium ratio 0.83 2.25 0.05 - 16.98  
Left breast      113 
Sodium, mmol/L   11.43 12.11 5.00 - 116.70  
Potassium, mmol/L 13.43 14.53 7.14 - 90.40  
Sodium/Potassium ratio  0.85 1.57 0.06 - 16.34  
1Normal values: sodium, 5-6 mmol/L; potassium, 13-14 mmol/L; sodium:potassium ratio, ≤ 0.6 . 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. Flow diagram of sample selection 
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Mother unavailable (n=21) 
Previously included in study (n=6) 
Refusal to participate (n=6)  
Mother’s age < 18 y (n=3) 
Twin births (n=1) 
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Figure 4.2. Sodium:potassium ratios of breast milk from lactating Ghanaian women, 
3-4 months postpartum, by subclinical mastitis (SCM) status 
 
Legend: 
Box plot categories represents women who had elevated Na/K in one breast (Unilateral, 
elevated), elevated Na/K in both breasts (Bilateral, elevated), normal Na/K in one 
breast(Unilateral, Non-elevated) and normal Na/K in both breasts (Bilateral, Non-elevated). 
The box plot includes: the 25th and 75th percentiles delineated by the box, the median is 
represented by the dark horizontal line, the whiskers represent 1.5 x interquartile range, 
outlier values (о) are 1.5-3 times the interquartile range, and extreme values (*) are more 
than 3 times the interquartile range. Dissimilar superscript letters represent significant group 
differences. 
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Chapter 5. Is subclinical mastitis associated with reduced breast milk 
intake? 
 
                                           A paper to be submitted to Pediatrics  
 
Richmond N.O. Aryeetey, PhD; Grace S. Marquis, PhD;                                                     
Leo Timms, PhD; Anna Lartey, PhD; Lucy Brakohiapa, PhD. 
 
Abstract 
OBJECTIVE: Subclinical mastitis (SCM) has been associated with infant growth 
faltering. The mechanism explaining this association remains unknown. We hypothesized 
that SCM is associated with reduced infant breast milk intake.  
METHODS: We compared 12-hour breast milk intake of infants of two groups of 
Ghanaian lactating mothers who either tested positive or negative for SCM. Only mothers 
above 18 years and between 3 and 6 months postpartum were included in this study. Breast 
milk intake was measured using test weighing. SCM positive mothers (N=37) were selected 
using the California mastitis test (CMT) score ≥ 1.0. Twenty three mothers had negative 
CMT scores. SCM diagnosis was confirmed using elevated breast milk sodium-potassium 
ratio (Na/K) > 1.0.  
RESULTS: Breast milk intake tended to be lower for infants whose mothers were 
diagnosed for SCM using elevated Na/K > 1.0 (-65.1 g; 95% CI: -141.3 g, 11.1 g). Infants 
whose mothers were positive for SCM with both CMT and Na/K had significantly lower 
breast milk intake (-88.9 g; 95% CI: -171.1 g, -6.9 g) compared to those whose mothers 
tested either negative with both tests or positive on only one. However, in multiple linear 
regression, infant weight (p<0.01) and frequency of feeding (p<0.01) but not maternal SCM 
status were associated with milk intake.  
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CONCLUSION: The major predictors of milk intake were infant weight and feeding 
frequency. The observed effect SCM status on milk intake is minimal and disappears when 
infant weight and feeding frequency are considered.  
  
Key words: breast milk intake, subclinical mastitis, infant, feeding frequency, Ghana 
Introduction 
There is compelling evidence that breastfeeding is associated with optimal infant 
growth and protection from diarrhea, respiratory infections, and other illnesses.1,2,3 However, 
some lactating women experience breastfeeding difficulties that may eventually lead to early 
cessation of breastfeeding or introduction of complementary feeding before the 
recommended six months.4,5  
A common problem that has been associated with lactation failure is subclinical 
mastitis (SCM).5 SCM is an inflammatory condition of the lactating breast that is thought to 
be caused by milk stasis or infections and has been associated with poor infant weight gain.5,6 
SCM is commonly diagnosed as either elevated breast milk sodium or sodium potassium 
ratio (Na/K). Milk sodium is considered elevated when it is above 16 mmol/L while Na/K is 
considered to be elevated above 1.0.5,6 Although SCM is most prevalent during early 
lactation, SCM rates of 12% to 23% at 14 weeks postpartum have been reported.7,8   
It is common knowledge in the dairy industry that cows diagnosed with SCM produce 
less milk.9 This evidence is further strengthened by the fact that calves fail to grow optimally 
when they are nursed by a cow with chronic mammary inflammation.9,10 Kitchen11 has 
reported a wide range of compositional and volumetric changes in dairy milk during SCM. In 
human lactation, however, little is known about the effects of compositional alterations in 
breast milk that are caused by SCM. The mechanism by which SCM affects weight gain 
among breastfeeding infants also remains unknown. 
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SCM commonly occurs in one breast.12 Milk output of the unaffected breast is 
capable of compensating for the affected breast without noticeable changes in common 
breastfeeding indicators. Conner13 has reported a single case in which an infant accepted milk 
from one breast with reluctance and nursed normally from the other. Tasting of the milk by 
the infant’s father showed that milk from the rejected breast had a salty taste. Later analyses 
showed that the sodium content of the affected breast was 103 mmol/L compared to a typical 
breast milk sodium concentration of < 10 mmol/L in non-weaning lactating women.14  
In this study we hypothesized that the mechanism linking infant growth faltering with 
SCM is the reduction of infant milk intake. The objective was to measure breast milk intake 
in infants of mothers with SCM and of mothers with normal breast health to determine 
whether reduced breast milk intake constitutes an explanatory variable linking infant growth 
faltering with maternal SCM.   
Methods 
Study area 
Data for this study were collected in the Manya Krobo district of Ghana between July 
2006 and February 2007. The Manya Krobo district is located in the Eastern region of Ghana 
and has a population of about 165,409.15 Sixty percent of households in the district live in 
rural communities. The major occupations of the district population include crop farming, 
fishing, and trading. A relatively high HIV prevalence of about 5% has been observed in 
Manya Krobo16 compared to the national HIV prevalence that is currently 2.7%.17 Previous 
studies in Manya Krobo suggest a high exclusive breastfeeding rate of 83.1% among three to 
six month old infants.18  
Participants 
A total of 72 mother-infant pairs were recruited from 7 child welfare clinics in the 
Manya Krobo district. Women were included in the study if they satisfied the following 
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criteria: at least 18 years old, singleton birth, less than three months postpartum and intending 
to breastfeed beyond three months postpartum.  
Data collection procedures 
At recruitment, field workers explained the protocol of the study to each eligible 
woman. Upon accepting the study procedures and signing the informed consent document, 
mothers were asked to provide their home addresses and an appointment was scheduled for a 
12-hour home observation visit on a date that was to occur after the infant turned three 
months old but was less than six months.  
Measurement of breast milk intake 
On the scheduled day of the home visit, field workers spent twelve consecutive hours 
at the residence of the mother to observe all infant breast milk intakes during the period using 
test weighing procedures. Test weighing involved the recording of the weight of the infant 
just before and then immediately after the infant received breast milk.19 Clothing or diapers 
worn by the infant were not changed between weighings. Test weighing measurements were 
recorded to the nearest 0.5 grams using the Sartorius EA15DCE-I digital scale (The Sartorius 
Group; Goettingen, Germany). The scale was calibrated weekly using standard weight 
blocks. Milk volume was calculated assuming 1g/ml.  
Maternal and infant anthropometry 
Anthropometric measurements that were recorded during the home visit included 
infant weight, length, head circumference, and mid-upper arm circumference as well as 
maternal height and weight. Infant weight was measured without any clothing. All weight 
measurements were recorded to the nearest 0.1 kilogram using the Tanita BWB800S digital 
floor scale (Tanita Corporation; Tokyo, Japan). Infant weights were measured by first having 
the mother stand on the scale without the infant, tarring the scale, and then recording the 
infant’s weight while being held by the mother, still standing on the scale. Head 
circumference and mid-upper arm circumference were measured to the nearest 0.1 centimeter 
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using a non-stretchable tape measure (Chasmors Ltd.; London, United Kingdom). Both infant 
length and maternal height were measured to the nearest 0.1 centimeter using the Shorr 
infant/child/adult height/length measuring board (Shorr Productions; Maryland, USA). Each 
anthropometric measurement was performed in duplicate by two field personnel who were 
trained and regularly standardized to perform maternal and infant anthropometric 
measurements using standard methods.20  
Morbidity and infant feeding 
During the home visit, maternal and infant health histories over the previous seven 
days were recorded. Mothers were asked to recall occurrence and frequency of any disease 
symptoms for both the mother (including fever, breast pain, engorgement, and sore nipple) 
and the infant (including diarrhea, cough, and fever). Any treatment for these symptoms and 
the source of treatment was also recorded. 
A food frequency questionnaire was used to record all dietary intake of the infant 
including breast milk and other liquid and solid foods. The questionnaire had a list of foods, 
including liquid, semi-solid and solid foods, as well as breast milk. Mothers were asked to 
recall intake of any of the listed foods or drinks taken by the infant and the frequency of 
intake of these items in the last 7 days. Mothers were also asked to indicate if the infant had 
any other foods that were not listed on the questionnaire.  
Breast milk collection and handling 
Breast milk samples were obtained one day prior to the scheduled 12-hour home visit. 
A sample of approximately 5 mL of breast milk expressed manually from each breast was 
obtained from each mother for analysis of sodium and potassium content. Before expressing 
breast milk, the women washed both hands thoroughly with disinfectant liquid hand soap and 
running water, rinsed with deionised water and dried their hands with clean paper towels. 
The first drops of expressed milk were discarded after which the nipple and surrounding 
areola were cleaned with cotton gauze soaked with 70% ethyl alcohol. Milk expressed 
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thereafter was collected in 60 mL plastic vials with snap-on caps. Upon completion of 
expression from one side, hand rinsing was repeated with deionised water and cleaning the 
breast surface with ethyl alcohol before milk was expressed from the other breast.   
About 2 mL of the milk sample were tested for SCM immediately after collection 
using the California mastitis test (CMT).21 The CMT is widely used by the dairy industry as 
an inexpensive and rapid ‘cow side’ screening test of SCM. We used the CMT to screen 
women for SCM during recruitment into the study. The SCM status was subsequently 
confirmed using sodium potassium ratio. The CMT involved mixing about 2 mL of milk with 
an equal amount of the CMT reagent in a test paddle and swirling the paddle in an 
anticlockwise fashion. Thickening or gelatinization of the mixture after about 10 seconds 
indicates SCM.21 The severity of SCM inflammation was observed as the extent of gel 
formation which was recorded on a scale of 1 to 3, with 3 representing the thickest gel 
formation. No gel formation was scored as a score of zero. 
The remaining milk sample was kept on ice in a sealed container and transported to 
temporary storage in the field laboratory at -20 0C. Subsequently, these samples were 
transported on ice to Accra for storage in a freezer at -32 0C until analyses for sodium and 
potassium content.  
Sodium and potassium analyses were carried out using the Medica Easylyte ion-
selective electrode analyzer (Medica Corporation; Bedford, USA). Samples were first thawed 
to room temperature (25 0C) and then homogenized before 0.1 mL of sample was aspirated 
into the Medica Easylyte ion-selective electrode analyzer for analyses. In addition to internal 
saline standards used by the Medica Easylyte analyzer, analytical quality was monitored by 
simultaneous analyses of milk with a saline standard with known electrolyte concentration.  
Statistical analyses 
All data analyses were performed using SPSS 15.0 (SPSS Inc; Chicago, USA). 
Descriptive statistics including arithmetic means and standard deviations were computed for 
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continuous maternal and infant descriptive variables. Categorical descriptive data were 
summarized into frequencies. Sodium-potassium ratios were computed from sodium and 
potassium data and categorized into SCM as follows: Na/K ≤ 1.0 indicating no SCM and 
Na/K > 1.0 indicating SCM. A CMT score ≥ 1 was considered a positive diagnosis for SCM. 
Group differences for categorical variables were tested using Pearson’s chi-square statistic. 
One-way Analyses of Variance was performed to test the difference in infant milk intake 
among SCM groups as well as the association with other maternal and infant factors. A 
multiple linear regression model was used to identify other infant and maternal factors 
associated with 12-hour milk intakes. 
Results 
Sodium and potassium data and CMT scores were available for 67 and 65 mothers, 
respectively. Five mothers had sodium and potassium data but not CMT scores while 7 
others had CMT scores but not sodium and potassium data. We only had complete data on 
sodium and potassium as well as CMT for 60 out of the 72 mother-infant pairs who 
participated in the study. Thus, only these 60 women were included in bivariate and 
multivariate analyses described below. About 62% of the mothers tested positive for SCM in 
one or both breasts using CMT ≥ 1. However, using Na/K > 1.0 as the threshold, only 26.9% 
of women tested positive for SCM in one or both breasts.  
Table 5.1 compares the characteristics of study participants across SCM groups based 
on Na/K. Women who tested positive for SCM tended to be younger (p=0.02) and were most 
likely to be first time mothers (p=0.02). There were no other significant differences in 
maternal characteristics between the SCM groups. Infant length was lower among infants 
whose mothers had elevated Na/K. There was, also, a tendency for lower infant weight 
(p=0.05) and head circumference (p=0.05) among infants whose mothers tested positive for 
SCM (Na/K > 1.0).  
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Average breast milk intake for all infants during the 12-hour observation was 407.7 ± 
127.2 g with a range between 173.5 g to 683.5 g. There was no difference in breast milk 
intake between infants whose mothers were diagnosed with a positive CMT score and those 
whose mothers who had a negative CMT score (403.9 ± 130.7 vs. 425.6 ± 121.8, 
respectively; p=0.52). Using Na/K for SCM diagnosis, however, there tended to be a lower 
milk intake (-65.1 g; 95% CI: -141.3 g, 11.1 g) among infants whose mothers had Na/K > 1.0 
compared to infants whose mothers had non-elevated milk Na/K. Figure 5.1 displays the 
distribution of milk intake among SCM groups as diagnosed by either CMT or Na/K. 
Eighteen percent (n=11) of mothers tested positive for SCM with both CMT and 
Na/K. Infants of these women (Figure 5.2) consumed significantly less breast milk (-88.9 g; 
95% CI: -171.1 g, -6.9 g) during the 12-hour observation period compared to those whose 
mothers were diagnosed either as negative on both SCM tests or positive for only one of the 
tests.  
In stepwise multiple linear regression analyses, factors that predicted infant milk 
intake included infant weight (p<0.01) and total number of breastfeeds (p=0.01) during the 
12-hour observations. Other factors that were included in the multiple linear regression 
model but which failed to predict milk intake included maternal SCM status, age, 
primiparity, and body mass index as well as infant gender, length, head circumference, and 
arm circumference.  
Discussion 
The objective of this study was to determine whether SCM status was associated with 
a decrease in infant milk intake and thereby serves as a mechanistic pathway by which SCM 
contributes to infant growth faltering.5,6 Our bivariate results showed that infants whose 
mothers were diagnosed with SCM using two diagnostic criteria (CMT score > 1 and Na/K > 
1.0) consumed significantly less milk (p=0.034). Multivariate analyses, however, revealed 
that infant weight and frequency of feeding, but not maternal SCM status, were the factors 
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that explained the variation in infant milk intake rather than SCM status. This outcome 
suggests that the difference in milk intake attributed to SCM was captured in multivariate 
analyses by either infant weight, feeding frequency or both.  
To our knowledge, this is the first study investigating the relationship between SCM 
and infant intake of breast milk beyond early lactation. Manganaro and collegues22 have 
recently reported an inverse relationship between breast milk sodium and infant milk intake 
during the first week postpartum. The results were also consistent with findings in dairy 
cattle in which SCM is known to reduce milk output and permanently impair lactational 
performance.11,23 
SCM typically occurs unilaterally and hence it is possible for milk output from a 
healthy breast to compensate for the adverse effect of SCM on an affected breast.24 As 
reported by Connor13 infants may be capable of differentiating between normal and breast 
milk with elevated sodium and thus exhibit a preference for the former. An ideal design for a 
study of the effect of SCM on lactational performance, therefore, would be to measure milk 
output from one breast independently of the other. Such a study should preferably impose 
minimal interference on the ‘on-demand’ feeding relationship between mother and infant. 
Daly et al.25,26 have demonstrated the capacity to measure milk output using a computerized 
breast measurement system that allows measurement of changes in breast volume. The 
technology and cost of such a study design is, however, not feasible in many laboratories and 
certainly not in the field setting that this study was performed.  
Elevated Na/K was more prevalent among younger and primiparous mothers in this 
study. A study in Zambia has also reported that primiparous mothers had significantly higher 
Na/K from the first through the 16th week postpartum.27 These findings have implications for 
interventions to support young and first time mothers to maintain optimal breast health 
during lactation.  
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In this study, we measured infant milk intake using test weighing as a proxy for milk 
output because it is a simple procedure and its effect on the maternal-infant feeding 
relationship is only minimal.19 Costs and logistics constrained us to use 12-hour test 
weighing sessions rather than a preferable 24-hour test weighing session. Matheny and 
Picciano28 have reported that a doubling of infant milk intakes observed during the day was 
not equivalent to intakes observed throughout 24-hour test weighing sessions. In this study, 
insensible water loss was not estimated. Arthur et al.19 have demonstrated significant 
underestimation of infant test weighing without consideration for insensible water loss. 
Although our comparisons across groups are not affected by not controlling for insensible 
water loss, it is probable that there was underestimation of milk intake across all subjects in 
our study. 
The CMT was used in this study as a screening test during recruitment because it is a 
simple and inexpensive diagnostic procedure that gives immediate results.21 In an earlier 
study, we had observed that the CMT overestimates the prevalence of SCM with the 
inclusion of the Trace score.18 Na/K which is commonly used to diagnose SCM6,7 was 
therefore used to confirm CMT scores. Using Na/K diagnosis, SCM rate was 27.7%. This 
was not an unexpected outcome based on what we had learned in other earlier studies we 
conducted in the same community.18  
Either CMT or Na/K alone failed to demonstrate significant differences in milk intake 
between infants based on their mothers’ SCM status. This may be explained by issues related 
to the thresholds for SCM diagnosis. Somatic cell count which forms the basis of the CMT is 
typically higher in cows than humans.29 The CMT’s diagnostic thresholds were designed and 
optimized to detect elevated somatic cell counts in dairy milk and therefore may exhibit 
different sensitivity levels in human milk. Na/K diagnosis is typically made using a threshold 
of 1.0, which is considered to be equivalent to a sodium concentration of 18 mmol/L.30 This 
level of milk sodium is typically observed in breast milk during mastitis in the absence of 
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weaning. However, it is not known whether the fluctuation in milk electrolytes observed 
during the onset of lactation or weaning follows the same pattern as the acute changes 
occurring in the milk of non-weaning lactating women.14 
Conclusions 
Our results indicate that infant weight and feeding frequency are the major 
determinants of infant milk intake. Maternal subclinical mastitis did not predict infant breast 
milk intake. Further studies are needed among infants less than three months to determine 
whether subclinical mastitis is associated with infant breast milk intake.   
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Table 5.1. Characteristics of Ghanaian lactating women and their infants by 
subclinical mastitis (SCM) status 
SCM status1  
Characteristics Negative (N=46) Positive (N=14) 
 
p-value3 
Maternal 
Age, y 26.8 (6.0) 2 23.7 (4.7) 0.02 
Education, y 7.6 (3.8) 7.5 (2.8) 0.23 
Body mass index, kg/m2 24.0 (3.1) 25.6 (5.0) 0.14 
Primipara, % 32.6 64.3 0.02 
Ill in last 7 days, % 23.9 7.1 0.08 
Fever in last 7 days, % 4.3 7.1 0.28 
Infant  
Age, mo 3.2 (0.1) 3.2 (0.1) 0.46 
Weight, kg  6.2 (0.9) 5.8 (0.6) 0.05 
Length, cm 60.5 (2.1) 59.5 (1.8) 0.04 
Head circumference, cm 40.1 (1.2) 39.6 (0.9) 0.05 
Mid-upper-arm circumference, cm 13.6 (1.2) 13.3 (0.6) 0.19 
Exclusively breastfed, % 87.0 78.6 0.18 
Male infants, % 43.5 50.0 0.34 
1 SCM defined as Na/K > 1.0  
2 Mean (SD) or % 
3 Group differences in continuous and categorical characteristics were tested with Student’s t-test 
and Pearson’s χ2 respectively; Fisher’s exact test used for three variables: Ill in last 7 days, Fever 
in last and Exclusively breastfed  
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Figure 5.1. 12-hour breast milk inake of Ghanaian infants by maternal subclinical 
mastitis (SCM) test 
Legend: 
(a) intake compared among California mastitis test score groups; (b) intake compared among 
sodium:potassium ratio groups. 
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Figure 5.2. 12-hour infant breast milk intake by maternal subclinical mastitis (SCM) 
status. 
 
Legend: 
Positive: Women whose breast milk had Na/K > 1.0 as well as CMT test score ≥ 1.  
Negative: Women whose breast milk had Na/K ≤ 1.0 and CMT score=0, or Na/K>1 and 
CMT score=0, or Na/K ≤ 1.0 and CMT≥1.   
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Chapter 6. Subclinical mastitis occurring between the third and sixth 
month postpartum does not predict growth of Ghanaian infants 
 
A paper to be submitted to Pediatrics 
 
Richmond N.O. Aryeetey, PhD; Grace S. Marquis, PhD; Leo Timms, PhD;                     
Anna Lartey, PhD; Lucy Brakohiapa, PhD; Mack Shelley, PhD 
 
Abstract 
INTRODUCTION. Subclinical mastitis (SCM) is a common inflammatory condition 
of the lactating breast that has been associated with growth faltering among infants during 
early lactation. We hypothesized that SCM continues to occur at a high rate beyond the third 
month postpartum and adversely affect infant growth. 
METHODS. A cohort of 115 lactating Ghanaian mothers and their infants were 
recruited and observed in seven consecutive home visits every two weeks between the third 
and sixth month postpartum. Infant feeding, anthropometric, and morbidity data as well as 
maternal socio-demographic, morbidity, and anthropometric data, and bilateral breast milk 
samples were collected at baseline and subsequent visits. Breast milk samples were analyzed 
for sodium and potassium to determine SCM status, defined as: No SCM (Na/K ≤ 0.6); 
moderate SCM (0.6 < Na/K ≤ 1.0); severe SCM (Na/K > 1.0). Outcome measures included in 
analyses were infant weight, length, head circumference, and mid-upper arm circumference 
at six months. 
RESULTS. At least 16% and 25% of mothers had severe and moderately elevated 
Na/K, respectively, in one or both breasts between the third and sixth month postpartum. 
There were no associations between SCM and any of the growth outcomes. The factors that 
predicted infant growth between the third and sixth month included infant gender and fever 
as well as maternal education, illness, nipple health, occupation, and parity.  
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CONCLUSION. Severe SCM occurring between the third and sixth month 
postpartum was common but not associated with infant growth. Intervention is needed in this 
community to reduce incidence of SCM, especially during the first six months postpartum. 
 
Key words: subclinical mastitis, growth, breastfeeding, Ghana 
Introduction 
Subclinical mastitis (SCM) is a common asymptomatic inflammation of the lactating 
breast and is thought to be caused primarily by milk stasis.1-4 Underlying factors that 
predispose women to SCM include poor lactation practice, poor anti-oxidant micronutrient 
status and localized or systemic infection.5-7 SCM is commonly diagnosed as elevated milk 
sodium or sodium-potassium ratio. Although SCM is most common during early lactation, 
the condition may occur beyond the third month postpartum.8,9 
SCM has been associated with growth faltering among infants during the first three 
months of lactation.3,10,11 The mechanism(s) by which SCM affects infant growth remains 
unknown. Morton11 has reported that elevated sodium is predictive of lactation failure. A 
recent study among Italian infants reported that elevated breast milk sodium is associated 
with reduced breast milk intake on the third day postpartum.12 Evidence from dairy cattle 
suggests a mechanism that involves reduced milk production.13 A case study reported by 
Connor14 suggested in 1979, that elevated breast milk sodium may be associated with 
reduced acceptability of breast milk by the infant. Although there are only few published 
studies on the association between SCM and infant outcomes, the ones outlined above 
provide important clues to the mechanistic pathway between SCM and infant growth 
faltering.  
Although there is a dearth of evidence to support a mechanistic pathway between 
SCM and infant growth faltering, a determination of the extent of growth faltering 
attributable to SCM is needed as growth is an important public health index of infant survival 
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and well-being and is listed as one of the indicators of the Millennium Development Goals.15 
A poor growth pattern during infancy and early childhood is associated with increased risk of 
infant mortality and severe morbidity linked with increased case fatality.16,17 Infants whose 
growth pattern becomes impaired experience more frequent episodes of gastrointestinal and 
respiratory tract infections.18,19 There is also evidence showing that growth impairment 
during infancy could delay mental development, reduce intellectual achievement, and 
subsequently lead to reduced work capacity in adulthood.16,20,21 Currently, one out of three 
children below five years are either underweight or stunted, globally.22 In sub-Saharan 
Africa, 38% of children below five years have low stature for their age. 
Earlier studies reporting an adverse effect of SCM on infant growth have focused 
mostly on infants up to three months old because SCM is most prevalent during early 
lactation.3,10 It is not known, however, whether the observed effect of SCM on infant growth 
persists beyond the first 3 months. The period between three to six months is important to 
observe because it is associated with the introduction of mixed feeding.23 Mixed feeding, in 
turn, is associated with elevated Na/K.1  
We observed a cohort of Ghanaian mother-infant pairs to determine the association 
between SCM and growth of children between the third and sixth month in a primarily peri-
urban Ghanaian community. We hypothesized that SCM occurs at a high rate beyond the 
third month postpartum and may affect infant growth during the three to six months period. 
Methods 
This prospective cohort study was conducted between February and October, 2006. 
The mother-infant pairs recruited into this study were observed during seven regularly 
scheduled home visits carried out approximately every two weeks over a total duration of 
three consecutive months between the 3rd and 6th month postpartum. All participants signed 
written informed consent forms that were approved by Iowa State University and the 
Noguchi Memorial Institute for Medical Research at the University of Ghana.  
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Study participants and procedures 
The study was carried out in the Manya Krobo district of the Eastern region of Ghana. 
The district has a population of 165,409 persons; mostly living in rural communities.24 More 
than 80% of residents are from the native Krobo ethnic group. The primary occupation is 
subsistence farming of vegetables and livestock. Most participants included in the study were 
recruited from peri-urban communities.  
Out of 2,718 lactating mothers attending the nine government child welfare clinics, 
163 satisfied all inclusion criteria: residence in the Manya Krobo district, less than 3 months 
postpartum, at least 18 years old, intention to breastfeed through the 6th month postpartum, 
and singleton birth. However, only 135 mothers agreed to participate in the study through six 
months postpartum.  
At recruitment, a brief demographic survey was collected together with the home 
addresses of participants using easy-to-identify land marks and community names and where 
possible, maps to the home were drawn. An appointment was scheduled with the mother for 
the day and time for the first home visit.  
Maternal and infant morbidity 
During each of the seven home visits, trained field workers collected maternal and 
infant morbidity data covering the seven days prior to the day of home visit. The mother was 
asked to recall the occurrence and frequency of occurrence of specific symptoms. Maternal 
symptoms included fever, breast pain, breast engorgement and sore/cracked nipples. Infant 
symptoms included diarrhea, cough, fever, breathing difficulty (unusual or labored breathing 
pattern), mouth sores and vomiting. Diarrhea was diagnosed as three or more liquid stools 
reported by the mother within a period of 24 hours.  
Dietary intake  
During each home visit, mothers and other caregivers were interviewed by field 
workers using a food frequency questionnaire to record all dietary intake of the infant, 
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including breast milk and other liquid, semi-solid and solid foods consumed by the infant 
during the last seven days. The questionnaire had a list of foods, including liquid, semi-solid 
and solid foods, as well as breast milk from which field workers asked the mothers to recall 
intake of any of the listed foods or drinks taken by the infant and the frequency of intake of 
these items in the last 7 days. Mothers were also asked to indicate if the infant had any other 
foods that were not listed on the questionnaire.  
Anthropometry 
Field workers were trained and regularly standardized to perform maternal and infant 
anthropometric measurements using standard methods.25 Maternal weight and standing 
height as well as infant weight, recumbent length, head circumference, and mid-upper arm 
circumference were measured and recorded at baseline. During subsequent visits, however, 
only infant anthropometric measurements were taken. 
Both maternal and infant weights were measured to the nearest 0.1 kg using the 
Tanita BWB800S digital floor scale (Tanita Corporation; Tokyo, Japan). Infant head 
circumference and mid-upper arm circumference were measured to the nearest 0.1 cm using 
a non-stretchable tape measure (Chasmors Ltd.; London, United Kingdom). Infant recumbent 
length and maternal standing height were both measured to the nearest 0.1 cm using the 
Shorr infant/child/adult height/length measuring board (Shorr Productions; Maryland, USA). 
All anthropometric measurements were taken in duplicate by a pair of field workers. The 
questionnaires were designed to ensure that field workers observed and recorded 
measurements independently of each other. After each measurement was recorded, field 
workers compared their measurements and if the difference exceeded maximum allowed 
differences, the particular measurement was repeated only once. 
Breast milk collection 
At each visit, a sample of 5 mL of breast milk was expressed manually from each 
breast. Breast milk samples were stored on ice in clean plastic vials with screw tops for 
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transportation to the field laboratory. An elaborate milk collection protocol was used to 
prevent contamination of the milk. Before expressing breast milk, the women washed both 
hands thoroughly with disinfectant liquid hand soap and running water, rinsed with deionised 
water and dried their hands with clean paper towels. The first drops of expressed milk were 
discarded after which the nipple and surrounding areola were cleaned with cotton gauze 
soaked with 70% ethyl alcohol. Milk expressed thereafter was collected using 60 mL plastic 
vials. Upon completion of expression from one side, hand rinsing was repeated with 
deionised water and breast surface cleaning with ethyl alcohol before milk was expressed 
from the other breast. All milk samples were then transferred into the screw top storage vials 
and transported on ice to the Noguchi Memorial Institute for Medical Research laboratories 
in Accra to be stored at -32 0C until analysis.  
Laboratory procedures 
Breast milk sodium and potassium analyses were performed using standard methods 
that employ ion selective electrode analyzer.26 Briefly, all analyses were performed on whole 
milk without any sample pre-treatment. Samples were first thawed to room temperature (25 0 
C) and then homogenized before 0.1 mL of sample was aspirated into the Medica Easylyte 
ion-selective electrode analyzer (Medica Corporation, Bedford, USA) for the analyses of 
sodium and potassium. In addition to internal saline standards used by the Medica Easylyte 
analyzer, analytical quality was monitored by simultaneous analyses of milk with a saline 
standard with known electrolyte concentration. Milk samples from left and right breasts were 
analyzed separately. 
Statistical analyses 
All data analyses were performed using SPSS 15.0 software (SPSS Inc; Chicago, 
Illinois, USA). Data obtained during the first home visit were considered as baseline. 
Maternal, infant and household characteristics were described using frequencies and 95% 
confidence intervals. Sodium:potassium ratios (Na/K) were computed and used for SCM 
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diagnoses as follows: no SCM (Na/K ≤ 0.6); moderate SCM (0.6 >  Na/K ≤1.0); severe SCM 
(Na/K > 1.0).1,11 Food frequency data were used to categorize infants into three feeding 
pattern groups: exclusive breastfeeding (given breast milk alone), predominant breastfeeding 
(breast milk plus water and other non-dietary fluids), and mixed feeding (breast milk plus 
other liquid and solid foods). Maternal weight and height obtained at baseline were used to 
compute maternal body mass index (BMI). Growth outcomes were reported as the difference 
between measurements taken at the 6th month and baseline as well as the attained growth 
measured at the sixth month. Infant growth measures were summarized using arithmetic 
means and standard deviations. Bivariate analyses of relationships between growth and 
categorical and continuous independent variables were tested using one-way analysis of 
variance and simple linear regression, respectively. Variables that were significant as well as 
had a priori theoretical associations with infant growth were included in the multiple linear 
regression models to determine the relationships between maternal and infant characteristics 
and infant growth (Table 6.5). Partial-F tests were then used to determine whether maternal 
SCM accounted for unexplained variance in the earlier model. Statistical significance was set 
at p<0.05, unless otherwise indicated. 
Results 
A total of 135 lactating mothers and their infants met the inclusion criteria and agreed 
to participate in the study (Figure 6.1). However, some mothers moved out of the study area 
or withdrew from the study prior to commencement of home visits. Baseline data were 
obtained from 115 mothers. Subsequently, more than 75% (n=87) of the mothers completed 
all the six remaining home visits while almost 89% (n=102) completed at least five out of six 
remaining home visits. Overall, a total of 747 out of 805 home visits were completed. A 
majority of visits (85%) were completed within ± 1 day of the scheduled visit dates. 
Emigration out of study area was the main reason for loss to follow-up; most of the emigrants 
had come to live temporarily with their family either prior to or immediately after delivery.  
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Eighty percent of study participants were between 18 and 30 years old and about 37% 
were primiparous. The median number of live births among the study participants was 2, 
with a range between one and six. Almost 90% of mothers had at least one year of education 
but only 16% had high school education. More than half of the mothers were petty traders 
and most lived in households with no pipe-borne water (83.5%), refrigerator (67.8%) or 
telephone (70.4%).  
A comparison of maternal and infant as well as household characteristics across 
baseline SCM groups is shown in Table 6.1. Maternal BMI was significantly higher (p<0.01) 
among mothers with severe SCM at baseline. All other maternal characteristics were not 
different across SCM groups. Overall, mothers were healthy as evidenced by the low 
incidence of reported disease symptoms during the entire study period. Overt breast health 
problems were uncommon among these mothers; only 1% of mothers reported either breast 
pain or cracked nipples during the study.   
At least 16% of mothers had severe SCM in one or both breasts at each visit (Figure 
6.2). The highest prevalence of severe SCM in one or both breasts, was observed at baseline 
(23.3%). Moderate SCM in at least one breast ranged between 25.2 and 37.5%. Therefore at 
each time during the study, about half of the mothers had moderate or severely elevated Na/K 
in one or both breasts. About 22% of mothers tested positive for severe SCM only once 
during the study period. Only 7% of mothers tested positive for severe SCM seven out of 
seven observation times during the study. 
The baseline sample included 52 male and 63 female infants. Most infants were born 
at home, thus, birth weight was unavailable for 70% of them. Compared to mothers, infants 
had a greater incidence of disease symptoms. For instance, reported coughing and difficult 
breathing episodes were documented in more than 20% of all home visits. Overall, diarrhea 
episodes were reported during 11% of home visits but only 4% of mothers reported blood in 
infant stools. There were no differences in the occurrence of any infant disease symptoms 
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across SCM groups. No deaths were reported among any of the mother-infant pairs during 
the study period.  
Over 88% of infants were breastfeeding exclusively at baseline and the rate of 
exclusive breastfeeding remained above 80% until the sixth month of age when it reduced to 
61% (Table 6.2). Mixed feeding was observed among 4% of infants at baseline and increased 
gradually through the 5th month. There was almost a 200% increase (n=10 to n=27) in the 
number of infants who were reported to be receiving liquid and solid foods in addition to 
breast milk between the 51/2 and 6th month home visit. The overall rate of mixed feeding 
during the study period was just above 11%. Infant feeding patterns did not differ across 
SCM groups at baseline (Table 6.1). 
On average, each infant gained 1.3 ± 0.4 kg in weight and added 5.5 ± 1.2 cm to their 
length between baseline and the seventh home visit. Tables 6.3 and 6.4 compare infant 
growth between baseline and the 6th month as well as attained growth measurement at all 
observed times during the study by maternal baseline SCM status. No consistent pattern was 
observed in the anthropometric indicators at any time point across baseline SCM groups. At 
all observed times, none of the group differences in weight, length, head circumference or 
mid-upper arm circumference was statistically significant. Episodes of severe maternal SCM 
during the 3rd and 6th months were not related to any of the growth measurements at any time 
point. 
In bivariate analyses, the strongest predictors of growth measurements at six months 
were the respective growth measurements at 3 months. Boys had greater growth 
measurements than girls (p<0.001). There was a tendency for head circumference (p=0.079) 
and recumbent length (p=0.067) to be associated with infant feeding during the 3rd month and 
4th months, respectively. Maternal BMI was directly associated with infant weight (p=0.017) 
but not length, head circumference, or mid-upper arm circumference at 6 months. No other 
maternal and infant characteristics were significantly associated with infant growth.  
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The outcomes of multiple linear regression analyses are shown in Tables 6.6. There 
was no effect of episodes of severe maternal SCM on infant growth measurements at 6 
months. Infant weight was directly associated with nipple soreness, and inversely with 
maternal education, and parity, after controlling for infant weight at 3 months, and maternal 
age. Length at 6 months was directly associated with maternal illness and inversely with 
infant fever episodes when length at 3 months as well as gender and parity were included in 
the model. Head circumference at 6 months favored boys and was lower in infants whose 
mothers were farmers. Maternal education was inversely associated with mid-upper arm 
circumference at 6 months.  
Discussion 
Elevated Na/K is considered an indicator of SCM and has been associated with infant 
growth faltering during early lactation, particularly during the first 3 months 
postpartum.3,10,11,27 Our study of Ghanaian infants did not observe an association between 
infant growth and SCM during this later period. Rather, in four out of seven measurements 
over time, we observed non-significantly greater average weight and head circumference 
among infants whose mothers had SCM at baseline. Infant mid-upper arm circumference 
measurements did not follow any consistent pattern when compared across baseline SCM 
status of the mother. Neither was any relationship observed between maternal episodes of 
severe SCM and infant growth. The observed outcomes were not altered with the inclusion of 
moderate SCM as a predictor of growth. With the exception of mid-upper arm 
circumference, more than 80% of the variation was explained by the variables included in the 
multiple linear regression models to explain growth measurements at 6 months.  
There are not many published studies that were designed to assess the relationship 
between SCM and infant growth. Most of the few published studies reporting an adverse 
impact of SCM on growth examined SCM and growth data collected during the first three 
months postpartum. One study from Zimbabwe included data up to four and half months of 
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age.10 To the best of our knowledge, this current study is the first to report the effect of SCM 
on growth between the third and sixth month postpartum. This study contributes to the 
existing literature on predictors of growth in Ghana where infant growth faltering often 
becomes evident early around the third month postpartum.23 
SCM is most common during the early postpartum period.8,9 We were unable to 
capture information on maternal SCM occurring earlier than the third month postpartum 
because our data collection was restricted to the period between the third and sixth month 
postpartum. Future studies of the cumulative effect of SCM on growth should include data 
from early lactation when SCM is most frequent. Also, a majority of infant birth weights 
were not available because most mothers delivered at home. Birth weight data, if available 
would have provided clues about the growth rate of infants during the first three months. In 
this current study, growth that occurred prior to the 3rd month was an important determinant 
of growth between the 3rd and 6th month postpartum. Therefore, the inability to control for 
SCM during the early postpartum period and lack of birth weight data may partly explain 
why we did not find any association between growth and SCM.10 It is necessary to also 
indicate the effect that low instrument precision may have had on the outcomes of this study. 
The Tanita BWB800S weighing scale used to measure infant weights only had a precision of 
0.1 kg. Mullany et al.28 have reported underestimation of poor infant growth performance 
using low precision measuring instrument. 
A third explanation for the observed outcomes may be drawn from the fact that the 
inflammation occurring during SCM appears to be an acute process.6 It is possible that SCM 
may become resolved, depending on maternal immune status, micronutrient status and 
maternal breastfeeding practices, before it influences infant growth. The effect of SCM on 
growth may therefore have a lesser impact during the third and sixth month when the infant 
is growing at a slower rate.  
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The high prevalence of severe SCM (20.7%) observed at the third month in our study 
is consistent with earlier publications: at 3 months postpartum, severe SCM ranges between 9 
and 25%.1,3,5,11 The wide range in the literature may partly be explained by whether milk 
samples used for analyses were obtained from only one breast at random, pooled from both 
breasts or analyzed separately and the results averaged between breasts. Several studies have 
shown that Na/K ratio is often different between breasts.5,8 Consistent with previous studies, 
breast health problems were rare among these women.7,29 Our results therefore show that 
subclinical mammary inflammation is common among Ghanaian lactating mothers from the 
third to the sixth month postpartum in the absence of overt symptoms.   
Maternal factors that were associated with infant growth included years of education, 
parity, illness, and fever. In contrast with previously published studies,30 maternal education 
was negatively associated with weight gain. We did not collect any data that could explain 
this outcome. However, based solely on the observations made during home visits, it appears 
that less educated women were less likely to be employed outside their home and/or more 
likely to be self employed. As a result, they may have more control of the time they needed 
to care and feed the infant. Reed et al.31 have demonstrated that higher maternal education 
was beneficial only when it correlated with a high socio-economic environment.  
The positive association between maternal illness and growth is opposite to what is 
expected; that is, maternal illness may adversely affect infant growth by reducing 
effectiveness of infant care and breastfeeding as reported in previous studies.32,33 The low 
incidence of maternal illness may have contributed to this outcome. As expected, length at 6 
months was lower among infants whose mothers had fever.    
Infant characteristics that were associated with growth were gender and fever. Boys 
had significantly greater weight, length, head circumference and mid-upper arm 
circumference at 6 months. This gender difference is a reflection of the observation that 
during the first 10 years of life, boys have greater average growth measurement compared to 
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girls.34 Infant fever was inversely associated with length at 6 months. Studies in similar 
settings have reported associations between history of fever and stunting among infants at six 
months and beyond.35,36 Infant illness may affect growth by increasing energy and nutrient 
requirements, reducing appetite for complementary foods, and limiting nutrient utilization.37-
39 
Conclusion 
We observed high rates of SCM among lactating Ghanaian women in the absence of 
overt breast health problems. Our study did not find an association between SCM and infant 
growth between the third and sixth month postpartum. Attained growth measures at six 
months were also associated with infant gender and fever as well as maternal illness, 
cracked/sore nipple, parity, and occupation. Our results have implications for targeting 
support for lactating mothers during the early postpartum period and to reduce the incidence 
of infant morbidity.  
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Table 6.1. Characteristics of Ghanaian lactating mothers and their infants at 
baseline (N=115) 
Subclinical mastitis status at baseline  
None/moderate           
(Na/K ≤ 1.0) 
Severe                
(Na/K > 1.0) 
Mother   
Age, y 25.8 (24.6, 27.0)1 26.0 (23.7, 28.2) 
Education, y 7.2 (6.4, 7.9) 6.5 (5.1, 7.1) 
Parity, # 2.2 (1.9, 2.4) 2.0 (1.5, 2.4) 
Body mass index, kg/m2 22.3 (21.6, 23.0) 25.0 (23.8, 26.1)a 
Married 96.6 100.0 
Earning income 90.6 92.9 
Fever 5.7 10.7 
Respiratory symptoms  9.3 15.4 
Infant   
Exclusively breastfed 88.5 78.6 
Weight, kg 5.9 (5.7, 6.0) 5.9 (5.6, 6.3) 
Length, cm 59.5 (59.0, 60.0) 59.7 (58.7, 60.7) 
Age, y 2.9 (2.9, 3.0) 3.0 (3.0, 3.0) 
Female 52.9 60.7 
Reported fever 12.7 10.7 
Household   
Electricity 71.3 85.7 
No running water at 
home  
82.8 85.7 
Own radio 64.4 71.4 
Own refrigerator 28.7 42.9 
1 Arithmetic mean (95% CI) or % 
a Significant group difference at p<0.01 
 
Table 6.2. Bimonthly feeding behavior of Ghanaian infants, 3-6 months old 
Infant age, mo Infant feeding  
behavior 
 3.0 3.5 4.0 4.5 5.0 5.5 6.0 Overall 
Exclusive 
breastfeeding, % 86.1 90.1 89.6 86.1 84.2 84.8 61.1 83.1 
Predominant 
Breastfeeding, % 9.6 4.5 2.8 4.0 4.0 4.8 9.3 5.6 
Mixed feeding, % 4.3 5.4 7.5 9.9 11.9 10.5 29.6 11.2 
N 115 111 106 101 101 105 108 747 
Exclusive breastfeeding: only breast milk fed to infant;  
Predominant breastfeeding: breast milk is major source of dietary intake, water and other non-
dietary fluids may be given;  
Mixed feeding:  liquid and solid foods given in addition to breast milk. 
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Table 6.3. Growth indicators of Ghanaian infants 3-6 mo, by maternal baseline 
subclinical mastitis (SCM) status 
SCM status1 Growth measure Infant age, 
mo No SCM2 Severe 
 
N 
3.0 5.8 ± 0.8 5.9 ± 0.9 115 
3.5 6.2 ± 0.8 6.2 ± 0.8 111 
4.0 6.4 ± 0.9 6.4 ± 0.4 106 
4.5 6.5 ± 0.9 6.8 ± 0.9 101 
5.0 6.8 ± 0.9 6.7 ± 0.7 101 
5.5 6.9 ± 0.9 7.1 ± 0.8 105 
Weight, kg 
6.0 7.1 ± 1.0 7.3 ± 0.6 107 
3.0 59.4 ± 2.1 59.7 ± 2.7 114 
3.5 60.7 ± 2.3 60.3 ± 2.1 111 
4.0 61.7 ± 2.3 61.4 ± 1.4 105 
4.5 62.4 ± 2.2 63.0 ± 2.5 100 
5.0 63.3 ± 2.3 63.1 ± 2.0 101 
5.5 64.2 ± 2.3 63.7 ± 1.9 105 
Length, cm 
6.0 65.1 ± 2.4 64.7 ± 1.9 105 
3.0 13.5 ± 1.0 13.6 ± 1.0 115 
3.5 13.8 ± 1.0 13.8 ± 1.0 111 
4.0 13.8 ± 1.1 13.8 ± 0.5 106 
4.5 13.9 ± 1.1 14.1 ± 1.0 101 
5.0 14.1 ± 1.1 14.2 ± 0.9 101 
5.5 14.0 ± 1.1 14.3 ± 1.0 105 
Mid-upper arm 
circumference, cm  
6.0 14.1 ± 1.1 14.4 ± 0.8 106 
3.0 39.7 ± 1.3 39.6 ± 1.5 115 
3.5 40.3 ± 1.4 40.1 ± 1.1 111 
4.0 40.7 ± 1.3 40.6 ± 1.3 106 
4.5 41.0 ± 1.3 41.3 ± 1.3 101 
5.0 41.4 ± 1.3 41.5 ± 1.1 101 
5.5 41.9 ± 1.3 41.7 ± 1.2 105 
Head circumference, 
cm 
6.0 42.2 ± 1.3 42.0 ± 1.0 106 
1 No SCM: Na/K ≤ 1; Severe SCM : Na/K>1 
2 Mean ± SD 
 
 
Table 6.4. Change in growth measurements of Ghanaian infants 3-6 mo, by maternal 
baseline subclinical mastitis (SCM) status 
SCM status2 Changes1 in growth measurements 
No SCM Severe N 
Weight gained, kg 1.3 ± 0.43 1.4 ± 0.3 108 
Length gained, cm 5.6 ± 1.2 5.4 ± 1.2 106 
Head circumference gained,  cm     2.5 ± 0.5 2.6 ± 0.6 107 
Mid-upper arm circumference gained, cm 0.5 ± 0.6 0.7 ± 0.5 107 
1 Difference in dependent variable measured at 6 months and at baseline (3 months) 
2 No SCM: Na/K ≤ 1; Severe SCM : Na/K>1 
3 Mean ± SD 
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Table 6.5. Variables from bivariate analyses that were included in multiple linear 
regression models of attained weight, length, head circumference, and mid-upper arm 
circumference at 6 months 
Dependent 
Variables 
Infant weight, kg Infant length, cm Head 
circumference, cm 
Mid-upper arm 
circumference, cm 
Independent 
variables 
Education 
Parity 
Infant age 
Breast pain2 
Breast 
engorgement3 
Cracked/sore 
nipples4 
Blood in stool6 
Weight at 3 months* 
SCM8 
Parity 
Infant gender* 
Maternal illness1 
Length at 3  
      months* 
Infant mouth sore5 
Infant fever7 
SCM8 
 
Occupation 
(farming) 
Infant gender* 
Head circumference 
at 3 months* 
SCM8 
 
Maternal education 
Occupation (office 
worker) 
Ethnicity (Akan) 
Mid-upper arm 
circumference* 
SCM8 
 
1 Reported maternal disease symptoms during 3rd – 6th month 
2 Reported breast pain during 3rd - 6th 
3 Reported breast engorgement/swelling during 3rd - 6th month   
4 Reported cracked/sore nipple during 3rd - 6th month   
5 Reported infant mouth sores during 3rd - 6th month 
6 Reported liquid stool with blood during 3rd - 6th month   
7 Reported infant fever during 3rd - 6th month 
8 Episodes of subclinical mastitis (SCM) during 3rd - 6th month; SCM defined as Na/K > 1 
* Statistically significant association with dependent variable at p<0.05 observed in bivariate analyses 
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Table 6.6. Factors associated with attained size in Ghanaian infants, 3-6 mo 
Explanatory variables Regression 
coefficient 
p-value F value  R2 
Weight at 6 months, kg    
Infant weight at 3 months, kg  0.97    <0.01 
Education, y -0.02      0.03 
Parity, # -0.09      0.03 
Maternal age, y  0.01      0.07 
Breast pain1 -0.19      0.12 
Cracked/sore nipple2  0.26      0.02 
Severe SCM episodes3  0.02      0.12 
71.18 0.84 
Length at 6 months, cm    
Gender (female) -0.42      0.03 
Length at 3 months, cm 0.85    <0.01 
Parity, # -0.15      0.04 
Maternal illness score4  0.23      0.01 
Infant fever5 -0.22      0.01 
Severe SCM episodes3 -0.06      0.11 
63.83 0.80 
Head circumference at 6 months, cm      
Head circumference at 3 months, 
cm 
 0.84    <0.01 
Gender(female) -0.25      0.06 
Severe SCM episodes3  0.02      0.13 
219.44 0.87 
Mid-upper arm circumference at 6 
months, cm 
  
Mid-upper arm circumference at 3 
months, cm 
 0.86    <0.01 
Maternal education, y -0.03      0.02 
Severe SCM episodes3  0.03      0.25 
78.02 0.70 
1 Reported breast pain during 3rd - 6th month 
2 Reported cracked/sore nipple during 3rd - 6th month 
3 Episodes of subclinical mastitis (SCM) during 3rd - 6th month; SCM defined as Na/K > 1 
4 Reported maternal disease symptoms during 3rd - 6th month 
5 Reported infant fever during 3rd – 6th month 
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Figure 6.1. Flow diagram of mother-infant pairs included in the study 
 
Legend: 
F: false address; R: relocated from study area; T: traveled; U: unavailable at home visit 
period; V: voluntary withdrawal. Number in parenthesis reflects pairs that were available for 
home visit after being unavailable during a previous home visit 
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Figure 6.2. Prevalence of subclinical mastitis (SCM) among Ghanaian lactating 
mothers , 3-6 mo postpartum 
 
 
Legend: 
No SCM: Na/K ≤ 0.6; Moderate SCM: 0.6 < Na/K ≤ 1.0; Severe SCM: Na/K > 1.0. 
Unilateral and bilateral refers to SCM diagnosis in one or both breasts, respectively.  
Severe/Moderate refers to a diagnosis of moderate SCM in one breast and severe SCM in the 
other breast. 
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Chapter 7. General Conclusions 
Subclinical mastitis (SCM) is an inflammatory condition of the lactating breast that 
affects many women. Studies on SCM have recently gained momentum because of the 
reported association between SCM and increased risk of HIV transfer from mother to infant 
via breast milk. In addition, the condition is known to affect lactation performance as well as 
have adverse effects on the growth of infants up to the third month of life. The mechanism 
for the effect of SCM on infant growth is unknown.  
The results of the studies carried out in Manya Krobo district indicate that SCM 
occurrence is high in the Manya Krobo district and probably elsewhere in Ghana. As 
reported in other studies, the majority of the observed SCM was unilateral. There is need, 
therefore, for interventions to reduce prevalence of SCM in this district. These interventions 
could be beneficial to both mothers and infants by reducing infant outcomes associated with 
SCM as reported in other studies.  
There was not sufficient evidence to support the hypothesis that SCM was associated 
with reduced infant breast milk intake in our study. Although significant differences were 
observed in breast milk intake across maternal SCM status in bivariate analyses, these 
differences disappeared in multivariate analyses. Infant feeding frequency, which is 
associated with both SCM and milk intake, and infant weight were the factors that explained 
the variation in breast milk intake.  The causal pathway(s) relating SCM and infant growth 
faltering remains unknown. Earlier studies reporting the association between SCM and infant 
growth faltering had involved infants at 3 months of age or less. In our study, all infants 
whose breast milk intake was assessed were between three and six months old. There is the 
need for future studies, therefore, to repeat the mechanistic study among infants below 3 
months to further examine the effect of SCM on milk intake.  
The outcome of the longitudinal study indicated that factors including infant gender 
and fever as well as maternal education, illness, nipple health, occupation, and parity 
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explained most of the variation in infant growth between the third and sixth month. No 
association was observed between episodes of SCM and infant growth during the same 
period. This outcome may partly be explained by the fact that SCM is most common during 
early lactation and therefore its effects on growth may be greatest during this early stage of 
growth. The early postpartum period is also associated with a faster infant growth rate which 
may explain why in the longitudinal study, we did not find any association between SCM and 
infant growth. Future studies on the effect of SCM on infant growth beyond 3 months 
postpartum may benefit from data on SCM and infant growth occurring during the early 
postpartum period.  
Altogether, these studies indicate that SCM is a common condition among lactating 
women. The reported maternal and infant outcomes may be limited to the early postpartum 
period prior to the third month. Simple interventions that reduced SCM prevalence using a 
single lactation counseling session either at birth or soon after birth have been demonstrated 
among Bangladeshi women. This approach may be useful among Ghanaian women because 
it is simple and inexpensive. 
In another study that has not been reported in this dissertation, we explored the use of 
simple SCM diagnostic tests from the dairy industry for use among lactating women. The 
simple tests investigated in that study were not sensitive compared to Na/K. There is 
therefore the need for future studies to continue to search for simple and inexpensive 
diagnostic tests for SCM among lactating women as this will be beneficial for identifying 
mothers with SCM, at least during the early postpartum period. 
It is thought that clinical mastitis results from and is a severe expression of SCM. 
Reducing SCM among lactating women is therefore important for reducing the risk of 
clinical mastitis. As reported in other studies, reducing SCM may reduce the risk of lactation 
failure and probably increase the duration of exclusive breastfeeding. Although our results do 
not show any association between SCM and either milk intake and growth of infants older 
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than 3 months, it is important to remember that SCM has been associated with both milk 
intake and growth faltering among infants below 3 months.  For the infant, reducing 
subclinical mastitis may result in reduced risk of HIV transmission.  
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Appendices 
 
Appendix 1:  Informed consent documents 
 
Appendix 1a: Rapid study informed consent document 
 
Title of Study:  Is subclinical mastitis a determinant of infants’ milk intake and growth: a 
rapid survey 
                           
Investigators: Grace S Marquis, PhD, Marcus Kehrli, PhD, Anna Lartey, PhD, Richmond 
Aryeetey, MPH 
 
This is a research study. Please take your time in deciding if you would like to participate.  
Please feel free to ask questions at any time. 
 
INTRODUCTION 
The purpose of this study is to obtain information about breast health among Ghanaian 
lactating women. Breast problems can affect the health of both lactating mothers and their 
children. There is currently no available information on breast health among Ghanaian 
women. Results from this study will be useful for improving recommendations for successful 
breastfeeding.  
You are being invited to participate in this study because you visited the child welfare clinic/ 
hospital today.  
 
DESCRIPTION OF PROCEDURES 
If you agree to participate in this study, you will be asked to answer questions in a brief 
interview.  You will also be asked to provide a one-time breast milk sample of about one 
spoonful of milk from each breast. These procedures will take approximately ten minutes. 
 
RISKS 
There are no foreseeable risks at this time from participating in this study.  
 
BENEFITS 
The results of the test that will be performed on your sample will be made available to you 
through the clinic within one week. It is hoped that the information gained in this study will 
benefit society by providing information that can be used to improve interventions aimed at 
improving maternal and child health.  
 
COSTS AND COMPENSATION 
You will not have any costs from participating in this study. You will receive a small token 
as compensation for your participation in this study.   
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PARTICIPANT RIGHTS 
Your participation in this study is completely voluntary and you may refuse to participate or 
leave the study at any time.  If you decide to not participate in the study, it will not result in 
any penalty or loss of benefits to which you are otherwise entitled.  
 
CONFIDENTIALITY 
Records identifying participants will be kept confidential to the extent permitted by 
applicable laws and regulations and will not be made publicly available. To ensure 
confidentiality to the extent permitted by law, the following measures will be taken. All 
records will be kept under lock and key with access only by the principal investigator or data 
management staff authorized by the principal investigator. Data stored on a computer will be 
managed by principal investigator with participants identified with codes. Names of 
participants will not be stored on the computer. If the results are published, your identity will 
remain confidential. 
 
QUESTIONS OR PROBLEMS 
You are encouraged to ask questions at any time during this study.  For further information 
about the study contact Dr Grace S Marquis, 1127 HNSB, Iowa State University, Ames, IA 
(USA); telephone number 515-294-9231 or Dr Anna Lartey, Dept. of Nutrition and Food 
Science, University of Ghana, Legon; telephone number 021-513-294. If you have any 
questions about the rights of research subjects or research-related injury, please contact 
Ginny Austin Eason, IRB Administrator, (515) 294-4566, austingr@iastate.edu, or Diane 
Ament, Research Compliance Officer (515) 294-3115, dament@iastate.edu.  
*************************************************************************** 
SUBJECT SIGNATURE 
Your signature indicates that you voluntarily agree to participate in this study, that the study 
has been explained to you, that you have been given the time to read the document and that 
your questions have been satisfactorily answered.  You will receive a copy of the signed and 
dated written informed consent prior to your participation in the study. 
 
Subject’s Name (printed) ____________________________________________________ 
 
____________________________   _______________________________ 
(Subject’s Signature)                                                 (Date)  
 
INVESTIGATOR STATEMENT 
I certify that the participant has been given adequate time to read and learn about the study 
and all of their questions have been answered.  It is my opinion that the participant 
understands the purpose, risks, benefits and the procedures that will be followed in this study 
and has voluntarily agreed to participate.    
 
______________________________       ____________________________ 
(Signature of Person Obtaining Informed Consent)      (Date) 
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Appendix 1b: Informed consent document for longitudinal study 
 
Title of Study:  Is subclinical mastitis a determinant of infants’ milk intake and growth: 
longitudinal study 
                           
Investigators: Grace S Marquis, PhD, Marcus Kehrli, PhD, Anna Lartey, PhD, Richmond 
Aryeetey, MPH 
 
This is a research study.  Please take your time in deciding if you would like to participate.  
Please feel free to ask questions at any time. 
 
INTRODUCTION 
The purpose of this study is to obtain information about breast health among Ghanaian 
lactating women. One common problem, subclinical mastitis, is a condition of the breast that 
cannot be seen but has health consequences for both lactating mothers and their children. 
There is currently no available information on subclinical mastitis among Ghanaian women. 
Results from this study will be useful in improving our recommendations for maintaining 
breast health among women.  
You and your child are being invited to participate in this study because you attended the 
child welfare clinic at this hospital.  
 
DESCRIPTION OF PROCEDURES 
If you agree to participate in this study with your child, your participation will last for a total 
of three months, starting from when your child is three months old. During each of the 7 bi-
monthly follow-up visits, you will be asked to answer questions on the health of you and 
your child, and your child’s feeding pattern. At each visit, breast milk samples (of about one 
tablespoonful) will be collected from each breast by our trained field staff who would also 
take measurement of your child’s growth. At the time of recruitment and also at the last 
follow-up visit, measurements of your weight and height will be taken. Each visit is expected 
to last for at least one hour at a venue of your choice (either your home or the hospital).  
 
RISKS 
There are no foreseeable risks at this time from participating in this study.  
 
BENEFITS 
It is hoped that the information gained in this study will benefit society by providing 
information that can be used to improve interventions aimed at improving maternal and child 
health.   
 
COSTS AND COMPENSATION 
You will not have any costs from participating in this study. You will receive a small token 
as compensation for your participation in this study.   
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PARTICIPANT RIGHTS 
Your participation in this study is completely voluntary and you may refuse to participate or 
leave the study at any time. If you decide not to participate in the study, it will not result in 
any penalty or loss of benefits to which you are otherwise entitled.  
 
CONFIDENTIALITY 
Records identifying participants will be kept confidential to the extent permitted by 
applicable laws and regulations and will not be made publicly available. To ensure 
confidentiality to the extent permitted by law, the following measures will be taken. All 
records will be kept under lock and key with access only by the principal investigator or data 
management staff authorized by the principal investigator. Data stored on a computer will be 
managed by principal investigator with participants identified with codes. Names of 
participants will not be stored on the computer. If the results are published, your identity will 
remain confidential. 
 
QUESTIONS OR PROBLEMS 
You are encouraged to ask questions at any time during this study.  For further information 
about the study contact Dr Grace S Marquis, 1127 HNSB, Iowa State University, Ames, IA 
(USA); telephone number 515-294-9231 or Dr Anna Lartey, Dept. of Nutrition and Food 
Science, University of Ghana, Legon; telephone number 021-513-294. If you have any 
questions about the rights of research subjects or research-related injury, please contact 
Ginny Austin Eason, IRB Administrator, (515) 294-4566, austingr@iastate.edu, or Diane 
Ament, Research Compliance Officer (515) 294-3115, dament@iastate.edu.  
*************************************************************************** 
 
SUBJECT SIGNATURE 
Your signature indicates that you voluntarily agree to participate in this study, that the study 
has been explained to you, that you have been given the time to read the document and that 
your questions have been satisfactorily answered.  You will receive a copy of the signed and 
dated written informed consent prior to your participation in the study. 
Subject’s Name (printed)               
____________________________    ________________________ 
(Subject’s Signature)        (Date)  
___________________________    ________________________ 
(Signature of Parent/Guardian or    (Date)  
Legally Authorized Representative) 
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INVESTIGATOR STATEMENT 
I certify that the participant has been given adequate time to read and learn about the study 
and all of their questions have been answered.  It is my opinion that the participant 
understands the purpose, risks, benefits and the procedures that will be followed in this study 
and has voluntarily agreed to participate.    
____________________________    ________________________ 
(Signature of Person Obtaining     (Date)  
Informed Consent) 
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Appendix 1c: Informed consent document for cross-sectional study 
 
Title of Study:  Is Subclinical mastitis a determinant of infants’ milk intake and growth: a 
cross-sectional study of breast milk intake 
                           
Investigators:   Grace S Marquis, PhD, Marcus Kehrli, PhD, Anna Lartey, PhD, Richmond 
Aryeetey, MPH 
 
This is a research study.  Please take your time in deciding if you would like to participate.  
Please feel free to ask questions at any time. 
 
INTRODUCTION 
The purpose of this study is to obtain information about breast health among Ghanaian 
lactating women. Breast problems can affect the health of both lactating mothers and their 
children. There is currently no available information on breast health among Ghanaian 
women. Results from this study will be useful in improving our recommendations for 
successful breastfeeding.  
You and your child are being invited to participate in this study because you attended the 
child welfare clinic at this hospital.  
 
DESCRIPTION OF PROCEDURES 
If you agree to participate in this study with your child, your participation will involve 
providing a breast milk sample collected at the clinic and a brief questionnaire. Thereafter a 
visit will be arranged to your home. During this home visit, which will last a trained field 
staff will measure the weight of your child before and after every time he/she is put to the 
breast to feed in order to know how much milk he/she drinks.  
 
RISKS 
There are no foreseeable risks at this time from participating in this study.  
 
BENEFITS 
At the end of the home visit, recommendations on infant feeding will be given to you. The 
information gained in this study will benefit society by providing information that can be 
used to improve interventions aimed at improving maternal and child health.  
  
COSTS AND COMPENSATION 
You will not have any costs from participating in this study. You will receive a small token 
as compensation for your participation in this study.   
 
PARTICIPANT RIGHTS 
Your participation in this study is completely voluntary and you may refuse to participate or 
leave the study at any time. If you decide not to participate in the study, it will not result in 
any penalty or loss of benefits to which you are otherwise entitled.  
 
146 
 
 
CONFIDENTIALITY 
Records identifying participants will be kept confidential to the extent permitted by 
applicable laws and regulations and will not be made publicly available. To ensure 
confidentiality to the extent permitted by law, the following measures will be taken. All 
records will be kept under lock and key with access only by the principal investigator or data 
management staff authorized by the principal investigator. Data stored on a computer will be 
managed by principal investigator with participants identified with codes. Names of 
participants will not be stored on the computer. If the results are published, your identity will 
remain confidential. 
 
QUESTIONS OR PROBLEMS 
You are encouraged to ask questions at any time during this study.  For further information 
about the study contact Dr Grace S Marquis, 1127 HNSB, Iowa State University, Ames, IA 
(USA); telephone number 515-294-9231 or Dr Anna Lartey, Dept. of Nutrition and Food 
Science, University of Ghana, Legon; telephone number 021-513-294. If you have any 
questions about the rights of research subjects or research-related injury, please contact 
Ginny Austin Eason, IRB Administrator, (515) 294-4566, austingr@iastate.edu, or Diane 
Ament, Research Compliance Officer (515) 294-3115, dament@iastate.edu.  
*************************************************************************** 
 
SUBJECT SIGNATURE 
Your signature indicates that you voluntarily agree to participate in this study with your 
child, that the study has been explained to you, that you have been given the time to read the 
document and that your questions have been satisfactorily answered.  You will receive a 
copy of the signed and dated written informed consent prior to your participation in the 
study. 
 
Subject’s Name (printed) ____________________________________________________
              
____________________________    ________________________ 
(Subject’s Signature)      (Date)  
 
 
Child’s Name (printed) _____________________________________________________ 
 
__________________________    ________________________ 
(Signature of Parent/Guardian or    (Date) 
Legally Authorized Representative of child) 
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INVESTIGATOR STATEMENT 
I certify that the participant has been given adequate time to read and learn about the study 
and all of their questions have been answered.  It is my opinion that the participant 
understands the purpose, risks, benefits and the procedures that will be followed in this study 
and has voluntarily agreed to participate.    
____________________________    ________________________ 
(Signature of Person Obtaining    (Date) 
Informed Consent) 
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Appendix 2: Rapid survey instruments 
 
Appendix 2a: Rapid survey questionnaire 
 
A Rapid survey of subclinical mastitis among Ghanaian breastfeeding women between the 
3rd and 4th month postpartum 
 
      Participant ID 
          ______ 
Date of Interview  (dd/mm/yy)        
          ___ / ___ / ___ 
Interviewer Identifier          
            ______ 
 
1. Mother’s Age (yrs) ____________           2.Community________________ 
 
3. Date of Delivery (dd/mm/yy)  ____/____/____  
 
4. Number of live births_______________________ 
 
5. Reason for Visiting Hospital       1. Child Welfare Clinic      2. Child Sick      
              3. Mother/Caregiver Sick              4. Other_______________________ 
 
6. How would you describe your health today?  1. Excellent/Good     2. As usual/Normal        
                                                                             3. Not Good/Bad      4. Cannot tell  
 
7. Indicate breast-related health problems:    
 Yes No If Yes, Indicate when: 
[1=Today; 2=In the last7 days; 3= in the last 7-14 days;  
4= Later than 14 days ago] 
Pain in the breast(s)    
Swollen breast/ 
Engorgement 
   
Cracked nipples    
Sore nipples    
Other(s), describe     
 
8. Have you had any other health problems in the last week?   1. Yes    2. No  (If yes, go to 9) 
 
9. Indicate the health problem(s)     1. Fever           2. Body Pains          3. Diarrhea                 
                                                         4. Waist Pains         5. Headache      
                                             6. Other ______________ 
 
            
10.                                                            1st       2nd 
Maternal MUAC (cm)     ___ ___ . ___           ___ ___ . ___ 
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11. Breast milk sample 
taken? (Y or N) 
Time Sample 
was collected 
Duration of milk  collection 
1= <5 Min          2= 5-10 Min    
3= 10-15 Min     4> 15 Min    
Left breast    
Right breast    
If No, reason:  
__________________________________________________________________________  
 
12.Comments_______________________________________________________________
__________________________________________________________________________ 
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Appendix 3: Longitudinal study instruments. 
 
Appendix 3a. Longitudinal study recruitment questionnaire 
 
A longitudinal study of breast health among Ghanaian breastfeeding women 
 
 Participant ID 
____ 
Date of Interview  (dd/mm/yy)  
    ___ / ___ / ___ 
Interviewer Identifier  
 ______ 
  
Mother’s Common Name_______________________                        
Community_______________________ 
 
Infant Characteristics 
1. Sex           1. Male         2. Female 
 
2. Child Date of Birth (dd/mm/yy) ____/_____/_____ 
 
3. Weight at birth (kg)   ____. ____ ____ 
 
Maternal Information 
4. Age (yrs)_________________________ 
 
5. Education (yrs)  _______________  
 
(Circle one)                            Post-Secondary 
None = 0                              Voc/Tech – started = 13 
Class 1–6 (Primary) = 1-6     Voc/Tech – completed = 14 
Junior Secondary School   JSS 1 = 7,   Prof. Diploma – started = 15 
JSS 2 = 8, JSS 3/Middle school completed = 9  Prof. Diploma – completed = 16 
Senior Secondary School       University – started = 17 
SSS 1 = 10, SSS 2 = 11, SSS 3 = 12    University – completed = 18  
                                                                                    Other/informal =19 
 
6. Ethnicity (Circle one)  1. Krobo       2. Ga/Adangbe       3. Ewe       4. Akan                         
                             5. Northerner          6.  Other_____________________________ 
 
7. Marital status (Circle one)    1. Married       2.  Cohabitant     3.  Single     4. Separated             
 
8. Number of Live Births________________________ 
 
9. Primary Occupation ________________________________________________ 
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10. Place of Work         1. Home           2. Outside home          3. Home + Outside Home         
                4. Not working currently  
 
11. If mother works outside home, do you take child with you?   1. Yes, all the time    
              2. Yes, sometimes        3. No 
 
12. Your current residence is:   1. Primary/Marital home       2. Parents’  home     
                                                  3. Other Relative’s home       4.Other __________________ 
 
13. How soon do you intend to move residence?     1. One Week or less        
                        2. Between One week and One Month      3. After one month or more          
                        4. After Three months                                5. Other _____________________ 
                      
 
15. Do you have the following in your home (Y/N): 
Electricity  Television  
Access to pipe-borne water  Radio/cassette player  
Mud  Telephone/cellular Phone  
Mud and Cement  Bicycle  
Blocks/Cement  Gas cooker  
Material of 
housing 
Aluminum Roofing  Refrigerator/Freezer  
   VCD/DVD  
 
Describe directions leading to household where mother presently resides (draw map at back!) 
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________ 
 
Contact information (Relative/Neighbour/Friend) 
Name _____________________________________________________________________ 
Address____________________________________________________________________
___________________________________________________________________________  
___________________________________________________________________________ 
Tel.no.__________________________________ 
 
Name _____________________________________________________________________ 
 
Address___________________________________________________________________        
__________________________________________________________________________ 
__________________________________________________________________________ 
__________________________________________________________________________ 
__________________________________________________________________________ 
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Tel.no.__________________________________ 
 
Describe directions leading to mother’s “Second” household 
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________ 
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Appendix 3b. Longitudinal study maternal and infant health questionnaire 
 
A Longitudinal study of breast health among Ghanaian breastfeeding women 
 
PartID 
 _____ 
Date Completed (dd/mm/yy)  
___ / ___ / ___ 
Interviewer Identifier    
 _____ 
 
Complete this health record starting from today(1) and track back to the last 7 days 
 
Time of interview: ____ :____(am/pm)                                           Visit #___________ 
 
*Informant ______________________  
 
Maternal and Child health record 
 Day of recall 1 2 3 4 5 6 7 
  Child health        
 1. # Total Stools        
 2a. # Liq Stools        
 2b. Mother thinks has diarrea (Y/N)        
 3. Blood (Y/N)        
 4. Vomit (#/day)        
* 5. Mouth sores         
* 6. Fever         
* 7. Cough        
 8. Difficulty breathing (Y/N)        
 9. Other ___________________        
* 10.Treatment        
 Maternal health        
* 11. Fever        
* 12. Illness        
 13. Pain in the breast (Y/N)        
 14. Swolleness in breast/engorgement 
(Y/N) 
       
 15. Sore/cracked Nipples (Y/N)        
* 16. Treatment        
* Refer to code list.             
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Code list 
Informant    Mouth
  
Fever Cough  Treatment 
0=no one available   0=none
  
0=no 0=no 0=none 
1=mother or guardian 
of child   
1=oral thrush
  
1=reported 
fever 
1=reported 
  
1=health 
professional 
2=family < 12 y who 
lives in house  
2=ulcers
  
2=fever 
observed  
2= observed
  
2=Traditional 
healer/TBA 
3=family ≥ 12 y who 
lives in house 
3=both 8=DK 
  
 3=home remedies 
4=neighbor 4=other    
     
Illness     
0=none     
1=respiratory      
2=gastrointestinal     
3=skin     
4=mouth lesions     
5=other specify     
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Appendix 3c. Longitudinal study home follow-up questionnaire 
 
A Longitudinal Study of breast health among Ghanaian breastfeeding women: follow-up 
 
PartID 
______ 
Date Completed (dd/mm/yy) 
 ___ / ___ / ___ 
Interviewer Identifier  
 ______ 
 
Visit #_________ 
 
1. Please tell me how often [child name] has received the following foods and/or liquids 
during last 7 days: 
Food item 1. Everyday                  2. 5-6 times a week  
3. 3-4 times a week      4. 1-2 times a week         
5. none  
Breast milk  
Cow’s milk  
Infant Formula  
Water  
Tea  
Porridge eg Koko, rice water   
Fruit juice, eg orange juice  
Soda eg  fanta, Coke  
Soup  
Bread  
Fruit  
Biscuit/Cookies  
Stew  
Solid foods eg rice, yam, cassava  
Animal foods eg fish, egg, beef  
Multivitamins/ codliver oil  
Ice Cream eg yoghurt, FanIce  
Other (write in) _________________  
Other (write in) _________________  
Other (write in) _________________  
 
2a. Did [child name] receive breast milk from anyone else apart from you (mother) in the last 
7 days? 
 1. Yes                      2. No                       3. Don’t know  
2b. If Yes to question 3, What is relationship of person to you? 
________________________________________________________________________ 
3. Breast milk sample taken? (Y/N) 
Left Breast  
Right Breast  
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If No,  reason_____________________________________________________________ 
 
 
Child Measurement  
 1A 1B 2A 2B 
Weight (kg)            ___ ___ . ___ ___ ___ . ___ ___ ___ . ___ ___ ___ . ___ 
Length (cm)           ___ ___ .___ ___ ___ .___ ___ ___ . ___ ___ ___ . ___ 
Head  
circumference (cm)    
___ ___ . ___ ___ ___ . ___ ___ ___ . ___ ___ ___ . ___ 
Arm  
circumference (cm)              
___ ___ . ___ ___ ___ . ___ ___ ___ . ___ ___ ___ . ___ 
 
 
Maternal Measurements 
 1A 1B 2A 2B 
Weight 
(kg)            
___ ___ . ___ ___ ___ . ___ ___ ___ . ___ ___ ___ . ___ 
Height 
(cm)           
___ ___ ___ . ___ ___ ___ ___ . ___ ___ ___ ___ . ___ ___ ___ ___ . ___ 
 
157 
 
 
Appendix 4. Cross-sectional study instruments 
 
Appendix 4a: Cross-sectional study recruitment questionnaire 
 
A study of breast milk intake by infants among Ghanaian breastfeeding women 
 
1. Date________________________ 
 
2. Name (include house name)__________________________________________ 
 
3. Age (yrs)_______________________                                                           
 
4. Is your child Breastfeeding?            1. Yes                  2. No 
 
5. Child date of birth ____/______/______        6. Clinic_______________________ 
 
House address (Describe address with detail) 
a._________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________ 
 
b._________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________ 
 
Telephone Number (if any)_______________________________ 
 
Draw directions to address 
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Appendix 4b. Cross-sectional study household questionnaire 
 
 
A cross-sectional study of breast milk intake among Ghanaian breastfeeding women 
 
PartID      
      _______ 
Date completed (dd/mm/yy)  
___/_____/_____ 
Interviewer identifier  
________ 
 
Place of interview  __________________________________________  
 
Maternal Information 
1. Age (yrs)_________________________ 
 
2. Education (yrs)  _______________ 
 (Circle one)                            Post-Secondary 
None = 0                              Voc/Tech – started = 13 
Class 1–6 (Primary) = 1-6     Voc/Tech – completed = 14 
Junior Secondary School   JSS 1 = 7,   Prof. Diploma – started = 15 
JSS 2 = 8, JSS 3/Middle school completed = 9  Prof. Diploma – completed = 16 
Senior Secondary School       University – started = 17 
SSS 1 = 10, SSS 2 = 11, SSS 3 = 12    University – completed = 18  
                                                                                    Other/informal =19 
  
3. Ethnicity (Circle one)  1. Krobo    2. Ga/Adangbe  3.  Ewe    4. Akan    5. Northerners                                
                                         6. Other____________ 
 
4. Marital status (Circle one)    1. Single     .  Cohabitants 3.  Married   4. Divorced 
 
5. Number of Live births_________________ 
 
6. Primary Occupation ________________________________________________ 
 
7. Place of Work         1. Home           2. Outside home          3. Home + Outside Home 
 
8. If works outside home, do you take child with you?   1. Yes , all the time    
                                            2. Yes, sometimes                3. No 
 
Mother                                                       1st                2nd 
9. Weight (kg)     ___ ___ ___ . ___  ___ ___ ___ . ___ 
 
10. Height (cm)                   ___ ___ ___ . ___   ___ ___ ___ . ___ 
 
Infant Characteristics 
11. Sex                      1. Male         2. Female 
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12. Weight at birth (kg)   ____. ____ ____ 
 
                                                              1st           2nd 
13. Weight (kg)                      ___ ___ . ___   ___ ___ . ___ 
 
14. Length (cm)                                ___ ___ ___ . ___  ___ ___ ___ . ___ 
 
15. Head circumference (cm)             ___ ___ . ___   ___ ___ . ___ 
 
16. Arm circumference (cm)                       ___ ___ . ___    ___ ___ . ___ 
 
17. Please tell me how often [child name] has received the following foods and/or liquids 
during last 7 days: 
 
Food item 1. Everyday                2. 5-6 times a week  
3. 3-4 times a week    4. 1-2 times a week         
5. none  
Breast milk  
Cow’s milk  
Infant Formula  
Water  
Tea  
Porridge eg Koko, rice water   
Fruit juice, eg orange juice  
Soda eg  fanta, Coke  
Soup  
Bread  
Fruit  
Biscuit/Cookies  
Stew  
Solid foods eg rice, yam, cassava  
Animal foods eg fish, egg, beef  
Multivitamins/ codliver oil  
Ice Cream eg yoghurt, FanIce  
Other (write in) _________________  
Other (write in) _________________  
Other (write in) _________________  
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Appendix 4c. Longitudinal study maternal and infant health questionnaire 
 
A Longitudinal study of breast health among Ghanaian breastfeeding women 
 
PartID 
 _____ 
Date Completed (dd/mm/yy)  
___ / ___ / ___ 
Interviewer Identifier    
 _____ 
 
Complete this health record starting from today(1) and track back to the last 7 days 
 
Time of interview: ____ :____(am/pm)                                            
 
*Informant ______________________  
 
Maternal and Child health record 
 Day of recall 1 2 3 4 5 6 7 
  Child health        
 1. # Total Stools        
 2a. # Liq Stools        
 2b. Mother thinks has diarrea (Y/N)        
 3. Blood (Y/N)        
 4. Vomit (#/day)        
* 5. Mouth sores         
* 6. Fever         
* 7. Cough        
 8. Difficulty breathing (Y/N)        
 9. Other ___________________        
* 10.Treatment        
 Maternal health        
* 11. Fever        
* 12. Illness        
 13. Pain in the breast (Y/N)        
 14. Swolleness in breast/engorgement 
(Y/N) 
       
 15. Sore/cracked Nipples (Y/N)        
* 16. Treatment        
* Refer to code list.             
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Code list 
Informant    Mouth
  
Fever Cough  Treatment 
0=no one available   0=none
  
0=no 0=no 0=none 
1=mother or guardian 
of child   
1=oral thrush
  
1=reported 
fever 
1=reported 
  
1=health 
professional 
2=family < 12 y who 
lives in house  
2=ulcers
  
2=fever 
observed  
2= observed
  
2=Traditional 
healer/TBA 
3=family ≥ 12 y who 
lives in house 
3=both 8=DK 
  
 3=home remedies 
4=neighbor 4=other    
     
Illness     
0=none     
1=respiratory      
2=gastrointestinal     
3=skin     
4=mouth lesions     
5=other specify     
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Appendix 4d. Breast milk intake assessment questionnaire 
 
A longitudinal Study of breast health among Ghanaian breastfeeding women: follow-up 
 
Household identifier __/__/__        Date completed __/__/__    
Interviewer identifier __ __ __ 
 
Complete this table during breast milk intake assessment 
 
           NUMBER OF BREASTFEEDS  
1 2 3 4 5 6 7 8 9 10 
Weight before feed (g)           
Weight after feed (g)           
Total weight of feed (g)           
HOURS                           TIME of FEED 
Hour began feed           
Hour finished feed           
Duration of feed (minutes)           
Total minutes on breast that 
didn’t feed 
          
Total minutes breastfeed            
Observations: 
 
